Acute Coronary Syndrome Types of Acute Coronary

z Infarction
and Myocardial Syndrome
Acute coronary syndrome (ACS)  Unstable Angina - Reduced
- ) is an emergent cardiac coronary blood flow causes
condition characterized by sudden chest pain, but no myocardial
myocardial ischemia that can lead damage occurs. Pain is not
to myocardial infarction (MI) if relieved by rest or nitroglycerin.
not treated promptly.
Ischemia – not getting enough  NSTEMI - non-ST-elevation
blood and oxygen. myocardial infarction. It is a
type of heart attack that usually
Infarction - tissue death due to happens when your heart’s
inadequate blood supply to the need for oxygen can’t be met.
affected area Some myocardial damage
Pathophysiology of Acute occurs, but ECG does not
show ST elevation.
Coronary Syndrome.
1) Plaque Rupture - ACS often
begins with rupture of an  STEMI - ST-elevation
atherosclerotic plaque in a myocardial infarction,
coronary artery, triggering clot Significant myocardial damage
formation. occurs with ST elevation on
ECG. STEMI occurs when a
ruptured plaque blocks a major
2) Reduced Blood Flow - The artery completely.
growing clot reduces blood
flow, causing myocardial
ischemia and chest pain.

3) Complete Occlusion - If the

artery becomes completely
blocked, myocardial infarction
occurs as heart muscle cells
die from lack of oxygen.
 Diagnosis of Acute
Coronary Syndrome
 Patient History
Detailed assessment of presenting
symptoms, previous cardiac
history, and risk factors.
 ECG
12-lead ECG to assess for ST-
segment changes, T-wave
inversion, and Q waves indicative
of ischemia/infarction.
 Cardiac Biomarkers
Blood tests for troponin, CK-MB,
and myoglobin to detect
myocardial cell death.
 Imaging
Clinical Manifestations of
Echocardiogram to evaluate
ACS
ventricular function and wall
 Chest Pain - Sudden onset of motion abnormalities.
chest pain or pressure that is
ECG Changes in
not relieved by rest or
nitroglycerin is the hallmark Myocardial Infarction
symptom. 1. T-Wave Inversion - Early sign
 Associated Symptoms - May of ischemia as myocardial
include shortness of breath, repolarization is altered.
nausea, anxiety, cool/pale skin, 2. ST-Segment Elevation -
and diaphoresis. Indicates acute injury, with ST
 Vital Sign Changes - elevation>1mm in two
Tachycardia, tachypnea, and contiguous leads diagnostic for
changes in blood pressure may STEMI.
occur due to sympathetic 3. Q-Wave Development -
stimulation. Abnormal Q waves appear
within 1-3 days, indicating
necrotic tissue.
4. Resolution - ST segment often  Nitroglycerin - Sublingual or
returns to baseline first. Q IV nitroglycerin for chest pain
waves may be permanent. relief.
 Morphine - IV morphine for
pain and anxiety if nitroglycerin
ineffective

Reperfusion Strategies
 Primary PCI
Preferred treatment for STEMI if
available within 90 minutes of first
medical contact.
 Fibrinolysis
If PCI not available, administer
Cardiac Biomarkers fibrinolytic therapy within 30
 Troponin - Most specific for minutes of arrival.
cardiac muscle. Rises within  Transfer for PCI
hours and remains elevated for
up to 2 weeks. Critical for If fibrinolysis contraindicated,
diagnosis. transfer for PCI, if possible, within
 CK-MB - Cardiac-specific 120 minutes.
isoenzyme. Rises within hours,
PERCUTANEOUS
peaks at 24 hours. Less
specific than troponin.
CORONARY
 Myoglobin - Rises rapidly INTERVENTION
within 1-3 hours but not 1. Coronary Angiography
cardiac-specific. Useful for
early detection or ruling out MI. Diagnostic imaging to locate
blockages in coronary arteries.
Initial Management of ACS
 Oxygen - Administer
supplemental oxygen to 2. Balloon Angioplasty
maintain saturation>95%. Inflation of balloon catheter to
 Aspirin - Give 162-325 mg compress plaque and open artery.
chewable aspirin immediately.

3. Stent Placement
Deployment of metal mesh stent to
maintain vessel patency.
Beta-Blockers in ACS
Mechanism: Reduce myocardial
4. Post-Procedure Care oxygen demand by decreasing
Antiplatelet therapy and monitoring heart rate and contractility.
for complications. Timing: Initiate within 24 hours if
no contraindications.
Thrombolytic Therapy
Benefits: Reduce recurrent
Indications: STEMI when PCI
ischemia, infarct size, and
unavailable within 120 minutes.
arrhythmias.
Must be given within 12 hours of
symptom onset Monitoring: Assess heart rate,
blood pressure, and signs of heart
Medications: Alteplase, reteplase,
failure.
or tenecteplase administered
intravenously. ACE Inhibitors and
Contraindications: Active ARBS (Angiotensin II
bleeding, recent surgery/trauma, receptor blockers)
uncontrolled hypertension, history
Indications: Initiate within 24
of hemorrhagic stroke.
hours for patients with anterior MI,
Monitoring: Assess for heart failure, or ejection fraction
reperfusion and bleeding <40%.
complications.
Benefits: Reduce ventricular
Antiplatelet and remodeling and mortality.
Anticoagulant Therapy Monitoring: Assess blood
 Aspirin - 81-325 mg daily to pressure, renal function, and
inhibit platelet aggregation. potassium levels.
 P2Y12 Inhibitors -
Clopidogrel, prasugrel, or Alternatives: ARBs if ACE
ticagrelor to further inhibit inhibitors not tolerated
platelets.
 Anticoagulants - Heparin or
low-molecular- weight heparin Nursing Assessment of
to prevent further clot ACS Patient
formation.
1. Pain Assessment
Evaluate chest pain Anxiety Reduction - Provide
characteristics, associated emotional support and clear
symptoms, and response to explanations of care.
interventions.
Monitoring for
2. Vital Signs Complications
Monitor heart rate, blood pressure,  Arrhythmias - Watch for new
respiratory rate, and oxygen onset of irregular rhythms,
saturation frequently. especially ventricular
3. Cardiac Monitoring arrhythmias.
 Heart Failure - Assess for
Continuous ECG monitoring for crackles, S3 heart sound, and
arrhythmias and ST-segment Increased dyspnea.
changes.  Cardiogenic Shock - Monitor
4. Perfusion for hypotension, cool
extremities, and decreased
Assess peripheral pulses, skin urine output.
color/temperature, and urine  Mechanical Complications -
output. Be alert for new murmurs
Nursing Interventions for indicating valve dysfunction or
septal rupture.
ACS
Pain Management
Administer prescribed medications Patient Education for ACS
and assess effectiveness. Medication Adherence
Oxygen Therapy Explain purpose and proper use of
Maintain oxygen saturation >95% all prescribed medications.
with supplemental oxygen as Risk Factor Modification
needed.
Discuss smoking cessation, diet
Activity Restriction changes, and exercise
Enforce bed rest during acute recommendations.
phase to reduce myocardial Warning Signs
oxygen demand.
Teach recognition of symptoms
requiring immediate medical
attention
Cardiac Rehabilitation Long-Term Management of
CAD (coronary artery
Phase I
disease)
Inpatient education and early
Medication Adherence
mobilization.
Continue antiplatelet therapy,
statins, beta-blockers, and ACE
Phase II inhibitors as prescribed.

Outpatient monitored exercise Risk Factor Control

program and risk factor education.
Maintain blood pressure, lipid, and
glucose targets.

Phase III Lifestyle Changes

Long-term maintenance of lifestyle Adopt heart-healthy diet, regular

changes and exercise habits. exercise, and stress management
techniques.
Regular Follow-up
Discharge Planning
Attend scheduled cardiology
Medications appointments and cardiac testing.
Ensure patient understands new IMMEDIATE TREATMENT OF
medication regimen. MYOCARDIAL INFARCTION
Follow-up Appointments "MONA TASS"
Schedule cardiology and primary MORPHINE
care visits.
OXYGEN
Cardiac Rehab Referral
NITROGLYCERIN
Arrange enrollment in outpatient
cardiac rehabilitation program. ASPIRIN

Lifestyle Modifications THROMBOLYTICS

Provide resources for diet, ANTICOAGULANTS

exercise, and smoking cessation. STOOL SOFTENERS
SEDATIVES Comorbidities

Coronary Artery Bypass Often have multiple chronic

Grafting conditions complicating
management.
Indications: Severe multivessel
disease or left main coronary Medication Considerations
artery stenosis. Increased risk of adverse effects;
Procedure: Creation of new may require dose adjustments.
routes for blood flow using arterial Functional Status
or venous grafts.
Assess and address impact on
Recovery: ICU care, ventilator activities of daily living.
weaning, pain management, and
cardiac rehabilitation. ACS in Patients with
Diabetes
Long-term Care: Lifelong
medication therapy and graft Silent Ischemia
patency monitoring.
Higher risk of asymptomatic or
Gender Differences in ACS atypical presentations.

Presentation Glycemic Control

Women may have more atypical Maintain blood glucose 140-180

symptoms like fatigue, nausea, mg/dL. during acute phase.
and back pain. Medication Adjustments
Age of Onset May need to modify diabetes
Women tend to develop CAD medications during hospitalization.
about 10 years later than men. Long-term Management
Outcomes Aggressive risk factor control
Women have higher mortality rates crucial for secondary prevention.
and more complications after MI.
Psychosocial Aspects of
ACS in Older Adults ACS
Atypical Presentation Anxiety and Depression
May present with fatigue, Common after ACS; screen and
confusion, or dyspnea rather than refer for treatment as needed.
chest pain.
Social Support Standardize medication
reconciliation and follow-up
Assess family dynamics and
planning.
available support systems.
Outcomes Tracking
Return to Work
Monitor readmission rates and
Provide guidance on appropriate
long-term patient outcomes.
timing and accommodations.
Sexual Activity
Telemedicine in ACS
Management
Address concerns and provide
education on resuming sexual ECG Transmission
activity safely. Remote interpretation of ECGs
New and Emerging from ambulances or rural
hospitals.
Therapies
Virtual Consultations
PCSK9 Inhibitors - Novel lipid-
lowering agents for high-risk Cardiology expertise for hospitals
patients. without 24/7 coverage.
Stem Cell Therapy - Experimental Remote Monitoring
treatments to regenerate damaged
Home-based systems for early
myocardium.
detection of decompensation.
Bioresorbable Stents - Dissolve
Telerehabilitation
over time, potentially reducing
long- term complications. Virtual cardiac rehab programs for
improved access and adherence.
Quality Improvement in
ACS Care Future Directions in ACS
Care
Door-to-Balloon Time
Precision Medicine
Aim for <90 minutes for primary
PCI in STEMI. Tailoring treatments based on
genetic and biomarker profiles.
Guideline Adherence
Artificial Intelligence
Implement protocols to ensure
evidence-based care. Machine learning algorithms for
risk stratification and treatment
Discharge Processes
selection.
Nanotechnology uses a balloon-tipped catheter to
open blocked coronary vessels
Targeted drug delivery systems for
and resolve ischemia. It is used to
improved efficacy and reduced
treat angina and acute coronary
side effects.
syndrome. The purpose is to
Prevention Strategies improve blood flow by
compressing atheroma in the
Novel approaches to identify and
coronary artery.
treat subclinical atherosclerosis.
Procedure:
Catheter Insertion - A balloon-
Invasive Coronary Artery
tipped catheter is inserted through
Procedures - are used to
the femoral or radial artery and
reperfuse ischemic myocardial
guided to the coronary arteries.
tissue when patients are refractory
to more conservative management
methods.
Balloon Inflation - The balloon is
The two main types are: inflated to compress the atheroma
and stretch the artery wall.
 Percutaneous coronary
interventions (PCIs)
 Coronary artery bypass graft
Stent Placement - A stent may be
(CABG) surgery.
positioned to maintain artery
Percutaneous Coronary patency after balloon withdrawal.
Interventions (PCIs) - are
invasive interventional procedures
performed through a skin puncture Coronary Artery Stents - are
rather than a surgical incision. metal mesh devices that provide
structural support to vessels at risk
The main types of PCIs are:
of acute closure after angioplasty.
 Percutaneous transluminal The stent is positioned over the
coronary angioplasty angioplasty balloon and expands
(PTCA) when the balloon is inflated,
 Intracoronary stent pressing against the vessel wall. It
implantation. is left permanently in place and
eventually becomes incorporated
into the vessel wall.
Percutaneous transluminal
 Bare Metal Stents
coronary angioplasty (PTCA) -
Original type, no medication get a GP IIb/Illa inhibitor to prevent
coating platelet aggregation.
 Drug-Eluting Stents Hemostasis is achieved by manual
pressure, closure devices, or
Coated with medications like
compression devices.
sirolimus or paclitaxel to minimize
thrombus or scar tissue formation Patients must remain flat in bed
or prevent restenosis until sheaths are removed and for
several hours after to maintain
 Stent Placement
hemostasis.
Expanded by balloon inflation, left
They are monitored for bleeding,
permanently in artery
hematoma formation, and
 Endothelialization vasovagal responses.

Stent eventually incorporated into 1 Immediate Post-PCI

vessel wall
Transfer to unit, anticoagulation,
PCI Complications hemostasis at access site

During Procedure: Artery 2 Early Recovery

dissection, perforation, closure, Bed rest, sheath removal,
vasospasm, Mi, arrhythmias, monitoring for complications
cardiac arrest
3 Later Recovery
After Procedure: Abrupt artery
closure, bleeding, hematoma, Ambulation, discharge planning,
retroperitoneal bleeding, arterial patient education
occlusion
Other Risks: Acute kidney injury Coronary Artery Bypass Graft
from contrast agent (CABG) Surgery - involves
Post-PCI Care grafting a blood vessel to an
occluded coronary artery to
After PCI, patients without restore blood flow.
complications may go home the
same day. Those treated for acute Major Indications: Uncontrolled
coronary syndrome typically go to angina, left main stenosis,
a critical care unit for monitoring. multivessel disease, PCI
Patients receive anticoagulation complications
with heparin or bivalirudin and may
Considerations: Number of Blood Withdrawal - Blood is
diseased vessels, LV function, withdrawn via cannula from the
comorbidities, symptoms, previous right atrium/vena cava
treatments
Outcomes: Similar to PCI for MI,
Oxygenation/Cooling -Blood
mortality, angina relief, lower
filtered, oxygenated, cooled by the
repeat intervention rate
machine
CABG Procedure
Anesthesia & Incision: General Return to Body - Via ascending
anesthesia, median sternotomy aorta. The heart is stopped with
cardioplegia solution. Hypothermia
(28°C) is maintained to decrease
Cardiopulmonary Bypass: metabolic rate. Heparin prevents
Patient connected to CPB clotting in the bypass circuit.
machine

Rewarming - Blood rewarmed

Graft Placement: Blood vessel after surgery and protamine
grafted to coronary artery sulfate reverses heparin effects.

Alternative CABG
Closure: CPB discontinued, chest Techniques
tubes and pacing wires are placed,
and the incision is closed. The Alternative CABG techniques have
patient is then admitted to a critical been developed with potential for
care unit for recovery and fewer complications.
monitoring.  Off- pump coronary artery
bypass (OPCAB) uses a
standard sternotomy but is
Cardiopulmonary Bypass - performed without
mechanically circulates and cardiopulmonary bypass. A
oxygenates blood, bypassing the stabilization device holds the
heart and lungs during surgery. heart still for grafting. OPCAB
may reduce short-term
morbidity but has lower long-
Procedure: term graft patency.
Minimally invasive techniques use Comprehensive preoperative
smaller incisions and robotic management is crucial for
systems to place grafts, with or preventing complications and
without CPB. These may allow Improving outcomes.
faster recovery and fewer
Key aspects include:
complications for select patients,
particularly for left anterior Medication Management: Aspirin,
descending artery bypasses. beta-blockers, statins
Health Assessment: Identify
complicating factors, baseline
CABG Complications status
Careful monitoring and prompt Patient Education: Procedure
intervention are essential to details, postop expectations
manage these complications.
Collaboration among the Psychosocial Assessment:
healthcare team is necessary to Anxiety, coping, support systems
achieve desired patient outcomes.
Cardiac: Hemorrhage,
Reducing Preoperative Fear
arrhythmias, MI, decreased output,
tamponade and Anxiety

Respiratory: Atelectasis, Nurses play a crucial role in

pneumonia, respiratory failure addressing patient and family
fears about cardiac surgery.
Other Systems: Neurological
changes, kidney injury, electrolyte Allow Expression of Fears
imbalances, infections Provide time for patients to voice
Postoperative Issues: Fluid concerns about pain, body image
overload, hypothermia, changes, disability, or death.
hypertension, postpericardiotomy Describe Expectations
syndrome
Explain sensations during different
phases, including preoperative
sedation, anesthesia, and
postoperative pain management.
Preoperative Nursing Address Specific Concerns
Management
Discuss pain control and close Intraoperative Nursing
monitoring, incision scarring Management
concerns, and mortality fears
Perioperative nurses are
Consider Medication responsible for patient comfort,
Antianxiety drugs for extreme safety, and assisting with the
cases not relieved by emotional surgical procedure.
support and education They perform assessments,
prepare the patient, and monitor
for complications like low cardiac
Preoperative Patient output, arrhythmias, hemorrhage,
Education myocardial infarction, organ
failure, and thromboembolic
Prior to surgery, nurses provide events.
specific instructions to patients
and families. Astute intraoperative
assessment is critical for early
Medication Instructions: detection and intervention.
Guidance on managing pre-
surgery medications; especially Before closing the chest, nurses
anticoagulants, antihypertensives, assist with inserting chest tubes
and diabetes medications. and temporary epicardial
pacemaker electrodes. They
Preop Hygiene: Antiseptic shower ensure proper functioning of all
and nasal decolonization to reduce equipment and prepare for
infection risk. immediate postoperative care.
Hospital Information: Details on
Immediate Postoperative
equipment, tubes, and
communication
Care

Nurses explain and practice deep Initial postoperative care focuses

breathing, coughing, incentive on achieving hemodynamic
spirometer use, and foot stability and anesthesia recovery.
exercises. Early ambulation Transfer: Move to ICU/PACU for
benefits are discussed. Family close monitoring, handoff report
questions about surgery length, (the surgical team communicates
communication, and visitation are important details to the receiving
addressed. nurses.)
Initial Assessment: prescribed. For severe cases,
Comprehensive system evaluation additional interventions like intra-
includes neurological status, aortic balloon pump placement
cardiac function, respiratory may be necessary.
status, fluid balance, and wound
condition. Promoting Adequate Gas
Exchange
Stabilization: Manage
hemodynamics, monitor vital Airway Management: Maintain
signs, urine output, chest tube endotracheal tube patency, suction
drainage and watch for s/s of as needed
bleeding, ventilation Monitoring: Assess arterial blood
Ongoing Care: Monitor for gases, ventilator parameters and
complications, pain control report changes promptly.

Maintaining Cardiac Output Positioning: Frequent changes to

optimize pulmonary ventilation and
Nurses continuously evaluate perfusion.
cardiac status through clinical
observations and measurements. Weaning/Extubation: Assist with
process, after extubation; deep
Hemodynamic Monitoring: breathing and coughing are
Blood pressure, heart rate, central encouraged every 1-2 hours to
venous pressure, arterial pressure, clear secretions and promote
and pulmonary artery pressures. effective ventilation. Nurses
Renal Function: Urine output continually assess respiratory
measurement as an indicator of status and intervene as needed to
renal perfusion and cardiac prevent complications like
function. atelectasis or pneumonia.

Clinical Assessment: Observe Maintaining Fluid and

for reduced output signs like Electrolyte Balance
cyanosis, neck vein distention, and
Nurses carefully assess fluid
arrhythmias. Any indications of
intake and output to determine
decreased cardiac output are
fluid balance.
promptly reported.
Intake Output Monitoring
Interventions: may include
IV fluids Urine Hemo-
administering blood products,
dynamics
fluids, antiarrhythmics, diuretics,
vasodilators, or vasopressors as
 sedatives (While historically used,
Oral Drainage Weight recent evidence suggests avoiding
intake haloperidol for delirium treatment.)
NG Insensible Electrolytes
Pain Management After
tube losses
Cardiac Surgery

Serum electrolytes are monitored, Assessment: Nurses assess

with close attention to potassium, patients for verbal and nonverbal
magnesium, sodium, and calcium pain indicators, recording the
levels. nature, type, location, and
duration.
Signs of dehydration, fluid
overload, or electrolyte imbalance Medication: Administer
are promptly reported. Nurses analgesics as prescribed.
work with providers to restore Multimodal analgesia using
balance and monitor response to opioids plus adjuncts like anti-
interventions like fluid inflammatories or muscle relaxants
administration or restriction, can improve pain control while
electrolyte replacement, or reducing opioid requirements.
diuretics. Non-pharmacologic: Teach
incision support techniques during
Minimizing Postoperative
coughing or deep breathing.
Confusion
Adequate pain control is crucial for
Postoperative delirium is a risk, promoting rest, reducing oxygen
especially in older patients. demand, and enabling
Assessment: Use Confusion participation in recovery activities.
Assessment Method for ICU
(CAM-ICU) to screen for delirium
Prevention Strategies: Maintaining Adequate
Reorientation, sleep promotion, Tissue Perfusion
maintaining day-night cycles,
Pulse Checks: Assess peripheral
minimize disruptions
pulses regularly to detect arterial
Continuity of Care: Consistent obstruction, Absent pulses are
staff, encourage family presence immediately reported.

Address Causes: Correct Embolism Signs: Monitor for

physiologic imbalances, avoid organ- specific symptoms; may
include chest pain, respiratory include anti-inflammatory
distress, abdominal pain, extremity medications.
changes, or neurological deficits.
DVT Prevention: Use
compression devices, promote Preparing for Discharge
mobility, avoiding knee elevation Discharge planning begins early,
Renal Function: Track urine typically 3-5 days post-surgery.
output, lab values Readiness Assessment:
Interventions for inadequate renal Evaluate ability to manage home
perfusion may include fluid care
administration, diuretics, or renal Education Plan: Develop
replacement therapy in severe individualized instructions covering
cases. incision care, infection signs, diet,
activity progression, breathing
exercises, weight monitoring,
Maintaining Normal Body medications, and follow-up
Temperature appointments.

Initial Hypothermia: Patients are Multiple Sessions: Provide

often hypothermic after surgery repeated education opportunities
due to induced cooling during Family Involvement: Include
cardiopulmonary bypass. Gradual caregivers in education process.
rewarming, monitor for They emphasize the ongoing
complications nature of cardiac disease
Normothermia: Maintain normal management and the importance
temperature, prevent infection of lifestyle modifications.

Fever Management: Identify

cause, Implement cooling
measures Home Care After Cardiac
Surgery
Postpericardiotomy Syndrome:
Recognize symptoms Home care nurses play a crucial
characterized by fever and other role in the transition from hospital
inflammatory symptoms, may to home.
occur days to weeks after surgery., Continued Education: Reinforce
assist with treatment which may hospital teachings
Health Monitoring: Check vitals,
incisions, assess for
complications, overall status
Wound Care: Perform dressing
changes as needed, diet
counseling, and smoking
cessation strategies.
Nurses reinforce the importance of
medication adherence and lifestyle
changes for ongoing heart health.
They encourage patients to
contact healthcare providers with
concerns and ensure patients
understand follow-up appointment
schedules. Home care nurses also
assess the need for additional
support services or referrals to
cardiac rehabilitation programs.

Cardiac Rehabilitation
Cardiac rehabilitation programs
provide comprehensive support for
recovery and lifestyle modification.
Exercise: Monitored physical
activity sessions
Education: Heart-healthy lifestyle
guidance
Support: Emotional and social
assistance
Risk Reduction: Help managing
cardiac risk factors and make
sustainable lifestyle changes.
Valvular Heart Disorders chordae tendineae anchoring
valve leaflets to papillary muscles.
Structural, infectious, and
muscles.
inflammatory disorders of the heart
present many challenges for
patients, families, and healthcare
teams.
Various mechanisms, heart valve
disorders, disorders,
cardiomyopathies, and infectious
diseases can alter cardiac alter
cardiac output.  Semilunar Valves
Treatments range from The pulmonic valve lies between
noninvasive approaches like the right ventricle and pulmonary
medication therapy and lifestyle artery. The aortic valve lies
changes to invasive procedures between the left ventricle and
such as valve repair or aorta. These valves control blood
replacement. flow from the ventricles into the
major arteries.
Nurses play Nurses play an
integral role in caring for patients  Valve Function
with these cardiac conditions. This
Heart valves control blood flow
presentation will explore the
through the heart by opening and
different types of valvular
closing in response to pre-
disorders, their pathophysiology,
pressure changes during the c
clinical manifestations, and
cardiac cycle of systole (contra
treatment options.
(contraction) and diastole
(relaxation).
Overview of Heart Valves
 Atrioventricular Valves
The tricuspid valve separates the Types of Valve Disorders
right atrium from the right ventricle.
 Regurgitation
ventricle. It has three leaflets.
Also called insufficiency, this
The mitral valve separates the left
occurs when valves do not close
atrium from the left ventricle and
completely, allowing blood to flow
has two leaflets. Both have
backward through the valve. valve.
 into the atrium during systole. May
lead to mitral regurgitation in rare
 Stenosis
cases.
This condition results when valves
Complications: Can result in
do not open completely, reducing
heart enlargement, atrial
blood flow through the valve.
fibrillation, pulmonary
hypertension, or heart failure.

 Prolapse
Specific to the mitral valve, Clinical Manifestations of Mitral
prolapse involves stretching of the Valve Prolapse
valve leaflet into the atrium during
systole.
Asymptomatic Cases: Most
people with mitral valve prolapse
 Combined Disorders never experience symptoms.

Regurgitation and stenosis may

occur simultaneously in the same
Common Symptoms: A small
or different valves.
number of patients may
experience fatigue, shortness of
breath, lightheadedness,
dizziness, syncope, palpitations,
chest pain, or anxiety.

Mitral Valve Prolapse

Fatigue: Patients may report
fatigue regardless of activity level
Prevalence: Occurs in up to 2.5%
and amount of rest or sleep
of the general population, twice as
frequently in women as in men.
Causes: Often no clear cause but Cardiac Symptoms:
associated with inherited
 Shortness of breath
connective tissue disorders
causing enlargement of mitral  palpitations
valve mitral valve leaflets.
 chest pain may occur in
Pathophysiology: One or both some cases.
mitral valve leaflets balloon back
 Symptom Monitoring: Instruct
patients to report any new or
changing symptoms to their
Diagnosis and Management of primary provider.
Mitral Valve Prolapse

Lifestyle Guidance: Encourage

Diagnosis: Often first detected by patients to read product labels,
an extra heart sound called a particularly over-the- the-counter
mitral click. Echocardiography medications, for ingredients that
is used to diagnose and monitor may produce arrhythmias or other
progression. symptoms.
Pregnancy Considerations:
Educate women that those without
Medical Management: Focused
mitral regurgitation or
on controlling symptoms. May
complications can safely complete
include eliminating caffeine,
pregnancies and have vaginal
alcohol, and tobacco.
deliveries.
Antiarrhythmic medications may
be prescribed if needed.
NURSING MNEMONICS & TIPS:
LEFT-SIDED HEART FAILURE
Surgical Intervention: Patients
"DO CHAP”
with severe mitral regurgitation
and symptomatic heart failure may DYSPNEA
require mitral valve repair or
ORTHOPNEA
replacement.
COUGH
HEMOPTYSIS
Nursing Management for Mitral
Valve Prolapse ADVENTITIOUS BREATH
SOUNDS
Patient Education: Educate
about the diagnosis and its PULMONARY CONGESTION
potential hereditary nature. Advise
screening for first-degree relatives.
Mitral Regurgitation
A condition where blood flows from
the left ventricle back into the left
atrium during systole due to 3. Ventricular Changes
incomplete closure of mitral valve
Increased blood volume from the
leaflets.
atrium causes ventricular
Common Causes: In developed hypertrophy. Eventually, the
countries: degenerative changes ventricle dilates, leading to systolic
of the mitral valve and left heart failure.
ventricular ischemia. In developing
countries: rheumatic heart
disease. 4. Pulmonary Effects
Other Causes: Infective Lungs become congested, adding
endocarditis, collagen vascular extra strain to the right ventricle.
diseases, diseases,
cardiomyopathy, cardiomyopathy,
and ischemic heart disease can
lead to functional or secondary
Clinical Manifestations and
mitral regurgitation.
Diagnosis of Mitral
Regurgitation
Pathophysiology of Mitral
Regurgitation
Symptoms:
Chronic cases often
1. Valve Dysfunction asymptomatic.
Problems with leaflets, chordae Acute cases may present with
tendineae, annulus, or papillary severe, sudden congestive heart
muscles lead to backward blood failure.
flow into the atrium during systole.
Common symptoms include
dyspnea, dyspnea, fatigue,
weakness, weakness, palpitations,
2. Atrial Changes
and cough from pulmonary
Excess blood causes the left congestion.
atrium to stretch, hypertrophy, and
hypertrophy, and eventually dilate.
This prevents normal blood flow Physical Examination: Systolic
from the lungs. murmur best heard at the apex,
may radiate to left axilla. Pulse
may be regular or irregular due to
extrasystolic beats or atrial Lifestyle Modifications: Patients
fibrillation. may be advised to limit physical
exertion and avoid competitive
sports until surgical intervention if
Diagnostic Tools: needed.
Echocardiography is primary tool
for diagnosis and monitoring
progression. progression. May Mitral Stenosis: Overview and
also use electrocardiography, Pathophysiology
exercise testing, and cardiac
Reduced blood flow from the left
catheterization with
atrium into the left ventricle due to
angiography.
narrowing of the mitral valve
orifice.
Cause: Usually caused by
rheumatic endocarditis, which
progressively thickens mitral valve
Management of Mitral leaflets and chordae tendineae,
Regurgitation causing leaflet fusion.

Medication: Heart failure Valve Changes: Normal mitral

medications including ACE valve orifice narrows from width of
inhibitors, ARBs, direct arterial three fingers to as small as a
dilators, and beta-blockers may be pencil in severe cases.
prescribed to manage symptoms
Cardiac Effects: Leads to left
and slow progression.
atrial hypertrophy, dilation,
Surgical Intervention: Mitral reduced ventricular filling, and
valvuloplasty (surgical repair) or decreased cardiac output. Can
valve replacement may be result in result in pulmonary
considered for patients with severe congestion and right ventricular
symptoms or progressive left strain. strain.
ventricular dysfunction.
Clinical Manifestations and
Monitoring: Regular Diagnosis of Mitral Stenosis
echocardiograms to assess
Initial Symptoms: Dyspnea on
disease progression: every 6
exertion is often the first
months for symptomatic patients,
symptom, caused by pulmonary
every 2-5 years for asymptomatic
venous hypertension. Symptoms
patients.
typically develop when valve
opening is reduced by one-third to strenuous activities, competitive
one-half. sports, and pregnancy.
Progressive Symptoms: Fatigue, Surgical Intervention: Options
decreased exercise tolerance, dry include valvuloplasty (usually
cough, wheezing, hemoptysis, commissurotomy), percutaneous
palpitations, orthopnea, transluminal valvuloplasty, or
paroxysmal nocturnal dyspnea, valve replacement for severe
and repeated respiratory infections cases. cases
may occur.
Physical Examination: Low-
Aortic Regurgitation: Overview
pitched, rumbling diastolic murmur
and Pathophysiology
best heard at the apex. Weak and
irregular pulse if atrial fibrillation Backward flow of blood into the left
develops. ventricle from the aorta during
diastole.
Diagnostic Tools:
Echocardiography is primary Causes: Can be congenital,
tool. May also use ECG, exercise inflammatory, infectious, or due to
testing, and testing, and cardiac aortic dilation or dissection.
catheterization with angiography to Common causes include bicuspid
determine severity. aortic valve.
Prevention and Management of Ventricular Changes: Left
Mitral Stenosis ventricle dilates to accommodate
increased blood volume, then
Prevention: Focus on preventing
hypertrophies to expel more blood
and treating bacterial infections,
with above-normal normal force.
infections, especially group A
streptococcal infections to Effects: Arteries attempt to
prevent acute rheumatic fever. compensate through reflex
Long-term term antibiotic vasodilation.
prophylaxis may be required for
Clinical Manifestations and
recurrent rheumatic fever.
Diagnosis of Aortic
Medical Management: Treat Regurgitation
congestive heart failure symptoms.
Symptoms: Often asymptomatic
Anticoagulants may be
initially. Some patients aware of
prescribed for severe left atrial
pounding or forceful heartbeat. As
dilation. Manage atrial fibrillation if
condition worsens, dyspnea on
it develops. Advise avoiding
exertion, fatigue, and signs of left Surgical Intervention: Aortic
ventricular failure may may valve replacement or
develop. valvuloplasty recommended for
symptomatic patients or those with
Physical Examination: High-
significant left ventricular dilation.
pitched, blowing diastolic murmur
at left sternal border. Widened Monitoring: Regular follow-ups to
pulse pressure. Water hammer assess symptom progression and
(Corrigan's) pulse may be present. left ventricular function.
Diagnostic Tools:
Echocardiography (preferably
Aortic Stenosis: Overview and
transesophageal), cardiac MRI, or
Pathophysiology
cardiac catheterization. Regular
echocardiograms for monitoring: Narrowing of the orifice between
monitoring: every 6 months if the left ventricle and aorta.
symptomatic, every 2-5 years if
Causes: Usually caused by
asymptomatic.
degenerative calcification in
Prevention: Focus on preventing adults. Less common causes
and treating bacterial infections, include congenital leaflet
especially those especially those malformations or malformations or
leading to rheumatic fever. rheumatic endocarditis.
Progression: Typically progresses
gradually over several years to
Management of Aortic
decades.
Regurgitation
Cardiac Effects: Left ventricle
Activity Modification:
contracts more slowly and forcibly
Symptomatic patients advised to
to overcome obstruction.
avoid physical exertion,
Ventricular wall hypertrophies
competitive sports, sports, and
due to due to increased pressure.
isometric exercise until valve
replacement.
Medication: ACE inhibitors and Management of Aortic Stenosis
dihydropyridine calcium channel and General Nursing Care for
blockers for hypertension Valvular Disorders
management. Beta-blockers used
Medical Management:
less commonly, Sodium restriction
Medications for arrhythmias or left
for symptomatic patients.
ventricular failure. Definitive
treatment is aortic valve Techniques to repair damaged
replacement, either surgical or valve leaflets, including removing
transcatheter (TAVR), Balloon excess tissue, plication, or
valvuloplasty for symptom relief patching holes with pericardium or
in in non-surgical candidates. synthetic material.
Nursing Assessment: Monitor
vital signs, heart and lung sounds,
Balloon Valvuloplasty
peripheral pulses. Assess for signs
of heart failure, arrhythmias, and Minimally Invasive Technique:
symptoms like dizziness or angina. Performed in cardiac
catheterization lab under light
Patient Education: Educate
sedation. Balloon catheter inserted
about diagnosis, disease
through blood vessels to reach the
progression, treatment plan,
stenotic valve.
medication management, and
importance of reporting new or Balloon Inflation: Balloon inflated
changing symptoms. Instruct on across valve to separate fused
endocarditis prevention and leaflets. May require multiple
lifestyle modifications. inflations to achieve desired
results.
Indications: Used for mitral and
Valvuloplasty: Repairing
aortic valve stenosis, less common
Cardiac Valves
for tricuspid and pulmonic valves.
 Commissurotomy May May be used as a bridge to
more definitive treatment.
Procedure to separate fused valve
leaflets, often used for mitral valve
stenosis. Can be performed as a
Valve Replacement Procedures
closed or open procedure.
 Surgical Valve Replacement
 Annuloplasty
Performed under general
Repair of the valve annulus to
anesthesia with cardiopulmonary
narrow the valve orifice. Uses an
bypass. Diseased valve removed
annuloplasty ring or suture
and prosthetic valve sutured in
techniques to tighten the tighten
place. place. Can be done through
the annulus.
full sternotomy or sternotomy or
 Leaflet Repair minimally invasive approaches.
approaches.
 Transcatheter Aortic Valve dysfunction without concurrent
Replacement (TAVR) hypertrophy.
Minimally invasive procedure Causes: Can be idiopathic,
performed in catheterization lab or familial, or secondary to various
hybrid OR. Bioprosthetic valve conditions including viral
delivered via catheter and infections, alcohol abuse, and
implanted within native aortic certain medications. medications.
valve. No cardiopulmonary bypass
Symptoms: Progressive heart
required.
failure symptoms including
dyspnea, fatigue, and edema. May
also experience arrhythmias and
Types of Prosthetic Heart Valves
thromboembolic events.
 Mechanical Valves
Treatment: Medical management
Made of durable materials like of heart failure. May require
pyrolytic carbon. Include bileaflet, mechanical circulatory support or
tilting disc, and caged ball designs. heart transplantation in advanced
Require lifelong anticoagulation cases.
but are very durable.
Hypertrophic Cardiomyopathy
 Bioprosthetic Valves (HCM)

Made from animal tissue (porcine, Genetic Disorder: Autosomal

bovine, or equine). Do not require dominant Inheritance. Leads to
long-term anticoagulation but have increased heart muscle size and
limited durability of 10-15 years. mass, especially along the
years. septum.

 Homografts Left Ventricular Outflow Tract

Obstruction: Can cause
Human cadaver valves
obstruction of blood flow from left
cryopreserved for transplantation.
ventricle to aorta. May lead to
Used for aortic and pulmonic valve
syncope, arrhythmias, and heart
replacement. Limited availability
failure.
and higher cost.
Surgical Management: Septal
Dilated Cardiomyopathy (DCM)
myectomy to relieve obstruction.
Most common form of Alcohol septal ablation as an
cardiomyopathy. Characterized by alternative in select cases.
ventricular dilation and systolic
Restrictive Cardiomyopathy Management: Lifestyle
(RCM) modifications, antiarrhythmic
medications, and implantable
Pathophysiology: Characterized
cardioverter-defibrillator (ICD)
by rigid ventricular walls that
placement in high-risk risk
impair diastolic filling. Normal or
patients.
near-normal systolic function.
Heart Transplantation
Etiology: Can be idiopathic or
secondary to infiltrative diseases 1) Candidate Selection
(e.g., amyloidosis), storage
Multidisciplinary team evaluates
diseases, or endomyocardial
potential recipients based on
disorders.
medical criteria, psychosocial
Diagnosis: Often requires factors, and expected outcomes.
endomyocardial biopsy for
2) Organ Allocation
definitive diagnosis.
Echocardiography shows United Network for Organ Sharing
preserved ejection fraction with (UNOS) manages waiting list
impaired diastolic filling. waiting list and organ allocation
based on various factors including
blood type, size match, and
Arrhythmogenic Right urgency.
Ventricular Cardiomyopathy
3) Transplant Procedure
(ARVC)
Orthotopic transplantation with
Inherited heart muscle disease
either biatrial or bicaval technique.
characterized by fibro-fatty
Recipient's diseased heart
replacement of right ventricular
removed, and donor heart
myocardium.
implanted.
Clinical Presentation: May
4) Post-Transplant Care
present with palpitations, syncope,
or sudden cardiac death. Often Lifelong immunosuppression,
affects young adults and athletes. close monitoring for rejection and
rejection and infection, and
Diagnosis: Combination of ECG
management of long-term
findings, imaging
complications.
(echocardiography, cardiac MRI),
and genetic testing. Ventricular Assist Devices
(VADs)
Types of VADs
 Pneumatic VADs Nursing Assessment of
Cardiomyopathy Patients
 Electric/Electromagnetic VADs
History Taking: Assess
 Axial Flow VADs
presenting symptoms, potential
 Centrifugal VADs etiologic factors, and impact on
impact on daily activities. Evaluate
Indications
for orthopnea, PND, and exertional
 Bridge to recovery
Physical Examination: Focus on
 Bridge to transplant signs of heart failure: jugular
venous distention, crackles on
 Destination therapy
lung auscultation, peripheral
Complications edema, and hepatomegaly.

 Bleeding Psychosocial Assessment:

Evaluate impact of disease on
 Thromboembolism
patient's role within family and
 Infection community. Identify support
systems and systems and assess
 Device malfunction
for depression.
Total Artificial Hearts
Functional Classification:
Current Status: SynCardia TAH Determine NYHA Functional
approved by FDA as bridge to Classification based on symptom
transplant. Requires removal of severity and limitations on physical
patient's native heart for activities.
implantation.
Nursing Interventions for
Limitations: Short-term success Cardiomyopathy
but disappointing long-term
Cardiac Output
results. Ongoing research to
develop permanent implantable Promote rest, administer oxygen
devices. as needed, ensure medication
compliance, and monitor daily
Future Directions: CARMAT TAH
weights.
undergoing early clinical trials in
Europe. Features biocompatible Increase Activity Tolerance
materials to potentially improve
Plan activities in cycles alternating
long-term outcomes.
rest and activity. Teach energy
conservation techniques and weight gain, increased dyspnea, or
symptom recognition. recognition. new-onset edema. edema.
Reduce Anxiety
Provide emotional support, Post-Heart Transplant Care
education about the disease
 Immediate Post-Op Care
process, and create an
atmosphere for open Close monitoring in ICU for
communication. hemodynamic stability, graft
function, and early signs of
Promote Self-Care
rejection or infection.
Educate about medication
 Immunosuppression
regimen, symptom monitoring, and
Management
lifestyle modifications. Encourage
patient involvement in care Initiation and titration of
decisions. immunosuppressive medications.
Education on importance of
Patient Education for
adherence and potential side
Cardiomyopathy Management
effects.
Medication Management: Teach
 Rejection Monitoring
importance of adherence, potential
side effects, and interactions. Regular endomyocardial biopsies
interactions. Assist in developing a and echocardiograms to assess to
medication schedule. assess for signs of rejection.
Teach patient to recognize
Diet and Fluid Management:
symptoms of rejection.
Educate on sodium restriction,
fluid balance, and weight  Long-Term Follow-Up
monitoring. Teach how to read
Ongoing surveillance for
nutrition labels and make
complications such as cardiac
appropriate food choices.
allograft vasculopathy,
Activity Guidelines: Instruct on malignancies, and opportunistic
balancing activity and rest. Provide infections.
guidance on safe exercise and
energy conservation techniques.
Ethical Considerations in VAD
Symptom Recognition: Teach
Management
signs and symptoms that require
medical attention, such as sudden 1. Device Deactivation
Ethical dilemmas surrounding feelings of guilt or indebtedness
patient requests for VAD towards donor.
deactivation. Balancing patient
autonomy with medical
beneficence.  Family Impact
2. End-of-Life Care Changes in family dynamics and
roles. Importance of involving
Challenges in providing palliative
family in education and support
care for patients with VADs.
processes.
Discussing advanced directives
and goals of care.  Long-Term Coping
3. Resource Allocation Addressing ongoing stress of
potential rejection or
Ethical considerations in patient
complications. Importance of
selection for VAD implantation,
support groups and mental health
especially as destination therapy.
resources.
4. Quality of Life
Balancing potential survival
Future Directions in
benefits with impact on quality of
Cardiomyopathy Management
life. Importance of shared
decision-making with patients and  Gene Therapy – Ongoing
families. families. research into genetic
modifications to treat inherited
cardiomyopathies.
Psychosocial Aspects of Heart
 Stem Cell Therapy - Potential
Transplantation
for cardiac regeneration using
 Pre-Transplant Period stem cells to repair damaged
myocardium.
Anxiety and uncertainty while
waiting for a donor organ. Coping  Advanced Mechanical
with deteriorating health and Support - Development of
lifestyle changes. smaller, more durable VADs
and fully implantable artificial
hearts.
 Post-Transplant Adjustment
 Personalized Medicine -
Adapting to new health status and Tailoring treatments based on
medication regimen. Dealing with
 genetic profiles and specific
disease mechanisms.

Conclusion: Comprehensive
Care for Cardiac Patients
Multidisciplinary Approach
Importance of collaboration
between cardiologists, cardiac
surgeons, nurses, and other
healthcare professionals.
Patient-Centered Care
Focusing on individual patient
needs, needs, preferences, and
quality of life in life in treatment
decisions.
Continuous Innovation
Ongoing advancements in surgical
techniques, device technology,
and medical management to
improve outcomes.
Holistic Management
Addressing not only physical
aspects of cardiac disease but
also psychological, social, and
spiritual needs of patients and
families.
Rheumatic Endocarditis Diagnosing Strep Throat
1. Strep Throat Infection Symptoms: Signs of strep throat
include sore throat, pain when
Acute rheumatic fever can develop
swallowing, fever, red and swollen
after an episode of group A beta-
tonsils, petechiae on the palate,
hemolytic streptococcal
and swollen lymph nodes.
pharyngitis, especially in school-
age children. Testing: A rapid strep test is
necessary to make an accurate
2. Rheumatic Fever
diagnosis. If negative but strep is
If left untreated, strep throat can still suspected, a throat culture can
lead to rheumatic fever, which may be done.
cause inflammation of the heart.
Treatment: Patients with positive
3. Rheumatic Heart Disease tests must adhere to prescribed
antibiotic treatment, typically
Patients with rheumatic fever may
penicillin or amoxicillin, to
develop rheumatic heart disease,
minimize risk of rheumatic fever.
evidenced by a new heart murmur,
cardiomegaly, pericarditis, and
heart failure.
Infective Endocarditis Overview
Infective endocarditis is a
Preventing Rheumatic Fever microbial infection of the
endothelial surface of the heart. It
Prompt Treatment: Prompt and
is rare but has a high mortality
effective treatment of strep throat
rate.
with antibiotics can prevent
development of rheumatic fever. Risk Factors: It usually develops
in older adults, people with
Risk Factors: Malnutrition,
prosthetic heart valves or cardiac
overcrowding, poor hygiene, and
devices, and IV drug users.
lower socioeconomic status may
Hospital-acquired cases occur in
predispose individuals to
patients with debilitating disease
rheumatic fever.
or indwelling catheters.
Declining Incidence: The
Mortality: Approximately 14% to
incidence of rheumatic fever in
22% of patients die during their
developed countries has
hospital stay, and up to 40% die
decreased and it is now primarily a
within 1 year of diagnosis.
disease of the developing world.
Pathophysiology of Infective  Cardiac Devices
Endocarditis
Implanted cardiac devices like
1. Initial Injury pacemakers and implanted
cardioverter defibrillators are risk
A deformity or injury of the
factors.
endocardium leads to
accumulation of fibrin and platelets  Congenital Heart Disease
(clot formation) on the
Unrepaired cyanotic disease and
endocardium.
repaired defects with prosthetic
material increase risk.
2. Bacterial Invasion  Other Factors
Infectious organisms, usually IV drug abuse, body piercing,
staphylococci or streptococci, hemodialysis, and cardiac
Invade the clot and endocardial transplant recipients with
lesion. valvulopathy are at higher risk.
Clinical Manifestations of
Infective Endocarditis
3. Vegetation Formation
Primary Symptoms: Fever and a
Infection results in platelets, fibrin,
heart murmur are the primary
blood cells, and microorganisms
presenting symptoms. Fever may
clustering as vegetations on the
be intermittent or absent in some
endocardium.
patients.
Skin Manifestations: Petechiae,
4. Complications Osler nodes, Janeway lesions,
and splinter hemorrhages may be
Vegetations may embolize to other
present.
vessels. Infection may erode
through the endocardium, causing Complications: Systemic
valve deformities or abscesses. embolization occurs in 22% to
50% of patients. Heart failure is
Risk Factors for Infective
the most frequent complication.
Endocarditis
Diagnosis of Infective
 Prosthetic Valves
Endocarditis
Prosthetic cardiac valves or
 Blood Cultures
prosthetic material used for
cardiac valve repair increase risk.
At least two sets of blood cultures Intravenous antibiotics are given
should be obtained before for 2 to 6 weeks to eradicate
antibiotic administration. invading organisms.
 Echocardiography  Monitoring
Echocardiography may Serum antibiotic levels and blood
demonstrate vegetations, cultures are monitored to gauge
abscesses, or new regurgitation. effectiveness.
 Laboratory Tests  Surgical Intervention
Patients may have elevated WBC Surgery may be required for heart
counts, anemia, positive failure, intracardiac abscess,
rheumatoid factor, and elevated recurrent embolizations, or
ESR or C-reactive protein. unresponsive infections.
Prevention of Infective Nursing Management of
Endocarditis Infective Endocarditis
 Antibiotic Prophylaxis Monitoring: Assess temperature,
heart sounds, and signs of
Prophylaxis may be reasonable for
embolization or organ damage.
high-risk patients before certain
dental procedures, but data is Infection Control: Practice good
mixed on its effectiveness. hand hygiene and monitor invasive
lines for signs of infection.
 Oral Hygiene
Patient Education: Educate
Good oral hygiene is crucial.
about activity restrictions,
Regular professional and personal
medications, and signs of
oral care can reduce the risk of
infection.
bacteremia.
Emotional Support: Provide
 Patient Education
support during prolonged
Patients should report prolonged treatment and facilitate coping
fevers and not self- medicate with strategies.
antibiotics.
Myocarditis Overview
Treatment of Infective
Myocarditis is an inflammatory
Endocarditis
process involving the myocardium.
 Antibiotic Therapy It can cause heart dilation, mural
thrombi, and degeneration of Activity Restriction: Young
muscle fibers. patients should limit activities,
especially athletics, for 6 months
Causes: It usually results from an
or until heart function normalizes.
infectious source (viral, bacterial,
fungal, etc.) but can also be Nursing Management of
immune-related or due to toxins. Myocarditis
Prognosis: Most patients with Assessment
mild symptoms recover
Monitor for resolution of symptoms
completely, but some develop
and signs of heart failure or
cardiomyopathy and heart failure.
arrhythmias.
Clinical Manifestations of
Medication Management
Myocarditis
Closely monitor for digitalis toxicity
Common Symptoms: Patients
in patients receiving this
may report fatigue, dyspnea,
medication.
syncope, palpitations, and
occasional chest discomfort. Thrombosis Prevention
Severity: Symptoms range from Use anti-embolism stockings and
asymptomatic to severe exercises to prevent venous
congestive heart failure or sudden thrombosis.
cardiac death.
Physical Findings: Assessment
Pericarditis Overview
may reveal tachycardia, cardiac
enlargement, faint heart sounds, Pericarditis is inflammation of the
or a systolic murmur. pericardium, the membranous sac
enveloping the heart.
Diagnosis and Management of
Myocarditis Classification: It can be acute,
chronic, or recurrent, with
Diagnosis: Endomyocardial
infectious or noninfectious causes
biopsy or cardiac MRI can
provide definitive diagnosis. Complications: It may lead to
pericardial effusion, cardiac
Treatment: Patients are given
tamponade, or constrictive
specific treatment for the
pericarditis.
underlying cause and placed on
bed rest to decrease cardiac Clinical Manifestations of
workload. Pericarditis
 Chest Pain Assist with positioning and provide
psychological support. Educate
The most characteristic symptom
about pain relief techniques.
is chest pain, which may worsen
with deep inspiration or when lying Monitoring:
down.
Be alert for signs of cardiac
 Pericardial Friction Rub tamponade and heart failure.
Monitor vital signs and heart
A creaky or scratchy friction rub
sounds.
heard on auscultation is the most
characteristic clinical Patient Education:
manifestation.
Educate about activity restrictions,
 Other Signs medications, and follow-up care.
Promote a healthy lifestyle to
Patients may have mild fever,
enhance the immune system.
increased WBC count, anemia,
and elevated ESR or C-reactive
protein.
Diagnosis and Management of
Pericarditis
Diagnosis: Diagnosis is based on
history, signs, and symptoms.
Echocardiogram, CT, or MRI may
be used for confirmation.
Treatment: Management includes
bed rest, pain relief with NSAIDs
or corticosteroids, and treatment of
underlying causes.
Procedures: Pericardiocentesis
may be performed to remove fluid.
Pericardiectomy may be
necessary for constrictive
pericarditis.
Nursing Management of
Pericarditis
Pain Management:
Heart Failure: A Chronic  Cardiomyopathy
Cardiovascular Condition
Disease of the heart muscle, such
Heart failure is a leading cause of as dilated cardiomyopathy, can
death in the United States, lead to progressive heart failure.
affecting millions of Americans.
 Valvular Heart Disease
Despite advances in treatment, it
remains a chronic and often Dysfunction of heart valves
progressive condition. increases cardiac workload and
can contribute to heart failure.
Heart Failure
Pathophysiology of Heart
Heart failure is a clinical syndrome
Failure
resulting from structural or
functional cardiac disorders that Decreased Cardiac Output
impair the heart's ability to pump
Heart failure results in reduced
blood effectively.
blood ejection from the ventricles.
Prevalence: Approximately 6
million Americans have heart
failure, with 870,000 new cases Neurohormonal Activation
diagnosed annually.
The body activates compensatory
Impact: Heart failure is the most mechanisms like the sympathetic
common reason for hospitalization nervous system and renin-
in people over 65 and has an angiotensin- aldosterone system.
economic burden of over $30
billion annually in the U.S.
Fluid Retention
Causes of Heart Failure
Neurohormonal changes lead to
 Coronary Artery Disease
sodium and fluid retention,
Atherosclerosis of coronary increasing blood volume.
arteries is a primary cause,
leading to ischemia and
myocardial dysfunction. Ventricular Remodeling
 Hypertension The heart undergoes structural
changes like ventricular dilation
Sustained high blood pressure
and hypertrophy.
increases cardiac workload and
can lead to ventricular
hypertrophy.
Types of Heart Failure Cough, nocturia, abdominal
bloating, and altered mental status
 Systolic Heart Failure
may occur.
(HFrEF)
Assessment of Heart Failure
Characterized by reduced ejection
fraction, typically less than 40%. Health History: Assess for
The left ventricle cannot contract symptoms like dyspnea, fatigue,
effectively. and edema. Evaluate sleep
patterns, activity tolerance, and
 Diastolic Heart Failure
dietary habits.
(HFpEF)
Physical Examination: Check for
Ejection fraction is preserved
signs of fluid overload, including
(250%) but the ventricle cannot
pulmonary crackles, peripheral
relax properly, impairing filling.
edema, and jugular vein
 Right-Sided Heart Failure distention.

The right ventricle fails to pump Diagnostic Test: Perform

effectively, leading to systemic echocardiogram to assess ejection
congestion. fraction. Obtain chest x-ray, ECG,
and laboratory studies including
Clinical Manifestations of Heart
BNP levels.
Failure
Congestive Heart Failure
 Dyspnea
NYHA Symptoms
Shortness of breath, especially
Class
with exertion or when lying flat
(orthopnea). Class I No symptoms and can
perform ordinary physical
 Fatigue
activity without limitations
Decreased exercise tolerance and
Class II Mild symptoms and slight
easy fatigability due to reduced
limitation of physical
cardiac output.
activity: No symptoms at
 Fluid Retention rest
Edema in extremities, pulmonary
congestion, and weight gain from
Class III Marked limitation of
fluid accumulation.
physical activity even with
 Other Symptoms less than ordinary activity
due to symptoms,
 Comfortable at rest Administration: Can be given
orally or intravenously. Dosage
Class IV Unable to carry out any
adjusted based on patient
physical activity, Severe
response and fluid status.
Limitations: Symptoms
present even at rest Monitoring: Assess daily weights,
fluid intake/output, electrolytes,
and renal function. Watch for signs
of dehydration or electrolyte
imbalances.
Pharmacologic Management of
Heart Failure Patient Education: Teach
importance of adherence,
 Diuretics
monitoring weight, and reporting
Reduce fluid overload and relieve excessive fluid loss or gain.
congestion. Examples include
ACE Inhibitors and ARBs in
furosemide and bumetanide.
Heart Failure
 ACE Inhibitors/ARBs
ACE Inhibitors
Decrease afterload and improve
Block conversion of angiotensin I
ventricular function. Examples
to angiotensin II. Examples:
include lisinopril and valsartan.
lisinopril, enalapril. Benefits
 Beta-Blockers include decreased afterload and
improved ventricular function.
Reduce workload on the heart and
improve survival. Examples Angiotensin Receptor Blockers
include metoprolol and carvedilol. (ARBS)

 Aldosterone Antagonists Block effects of angiotensin II at

receptor sites. Examples:
help people get excess water and valsartan, losartan. Used as
salt out of their bodies without alternatives to ACE inhibitors if not
losing potassium. tolerated.
Diuretic Therapy in Heart Failure Monitoring
Indications: Used to reduce fluid Assess blood pressure, renal
overload and relieve symptoms of function, and potassium levels.
congestion in heart failure Watch for side effects like cough
patients. (with ACE inhibitors) or
angioedema.
Beta-Blockers in Heart Failure Intravenous Therapies for Acute
Management Heart Failure
Mechanism: Block effects of  Diuretics
sympathetic nervous system on
IV furosemide for rapid diuresis in
the heart, reducing workload and
acute decompensated heart failure
improving function over time.
 Inotropes
Benefits: Improve survival, reduce
hospitalizations, and enhance Dobutamine or milrinone to
quality of life in heart failure improve cardiac contractility in
patients. severe heart failure.
Administration: Started at low  Vasodilators
doses and gradually titrated up to
Nitroglycerin or nitroprusside to
target dose as tolerated.
reduce preload and afterload in
Monitoring: Assess heart rate, acute situations.
blood pressure, and signs of fluid
retention. Watch for side effects
like fatigue or dizziness. Non-Pharmacological
Management of Heart Failure
Dietary Modifications
Aldosterone Antagonists in
Heart Failure Sodium restriction (2-3 g/day) and
fluid restriction as needed.
Mechanism: Block effects of
aldosterone, reducing sodium and Exercise
fluid retention.
Structured exercise programs to
Indications: Used in moderate to improve functional capacity and
severe heart failure to improve quality of life.
symptoms and survival.
Weight Monitoring
Monitoring: Closely monitor
Daily weight checks to detect early
potassium levels and renal
fluid retention.
function. Risk of hyperkalemia.
Patient Education
Examples: Spironolactone and
eplerenone are commonly used
aldosterone antagonists.
Device Therapies for Heart
Failure
 Implantable Cardioverter Promoting Self-Care in Heart
Defibrillators (ICDs) Failure
Detect and treat life-threatening Daily Weighing
arrhythmias in high-risk heart
Instruct patients to weigh
failure patients.
themselves daily and report gains
 Cardiac Resynchronization of 2-3 pounds in a day.
Therapy (CRT)
Medication Adherence
Biventricular pacing to improve
Educate on importance of taking
cardiac synchrony and function in
medications as prescribed and
select patients.
potential side effects.
 Left Ventricular Assist
Symptom Monitoring
Devices (LVADs)
Teach patients to recognize and
Mechanical pumps to support
report worsening symptoms like
circulation in advanced heart
increased shortness of breath or
failure, either as bridge to
edema.
transplant or destination therapy.
Lifestyle Modifications
Guide patients on dietary changes,
Nursing Care for Heart Failure
exercise recommendations, and
Patients
stress management techniques.
Assessment: Regular monitoring
Managing Acute
of vital signs, weight, fluid status,
Decompensated Heart Failure
and symptoms.
Initial Assessment: Rapid
Medication Management:
evaluation of respiratory status,
Administering and educating about
hemodynamics, and congestion.
heart failure medications.
Oxygen Therapy: Provide
Patient Education: Teaching self-
supplemental oxygen as needed
care skills, symptom recognition,
to maintain adequate saturation.
and when to seek medical
attention. IV Diuretics: Administer IV loop
diuretics to promote rapid diuresis
Psychosocial Support:
and symptom relief.
Addressing anxiety, depression,
and quality of life concerns. Hemodynamic Support:
Consider vasodilators or inotropes
if needed for hemodynamic Atrial fibrillation, poor ventricular
stabilization. function, and immobility increase
risk of thromboembolism.
Palliative Care in Advanced
Heart Failure Prevention
Symptom Management Anticoagulation therapy for high-
risk patients. Encourage early
Focus on relieving symptoms like
mobilization when possible.
dyspnea, pain, and fatigue to
improve quality of life. Management
Advance Care Planning Prompt recognition and treatment
of deep vein thrombosis or
Discuss goals of care, treatment
pulmonary embolism. May require
preferences, and end-of-life
thrombolytic therapy in severe
wishes with patients and families.
cases.
Psychosocial Support
Pericardial Effusion and Cardiac
Address emotional, spiritual, and Tamponade
social needs of patients and
Pericardial Effusion
caregivers.
Accumulation of fluid in the
pericardial sac, which can
Cardiogenic Shock compress the heart if severe.

Severe impairment of cardiac Cardiac Tamponade

function leading to inadequate
Life-threatening condition where
tissue perfusion.
pericardial fluid severely impairs
Causes: Often results from acute cardiac filling.
myocardial infarction or end-stage
Symptoms: Dyspnea, chest pain,
heart failure.
hypotension, and pulsus
Clinical Signs: Hypotension, paradoxus in severe cases.
altered mental status, cool Treatment: Pericardiocentesis to
extremities, and oliguria drain fluid in acute tamponade.
Treat underlying cause.
Thromboembolism in
Cardiovascular Disease Cardiac Arrest

Risk Factors 1) Recognition

Immediate assessment for services should be called
responsiveness and breathing. immediately.
Check for pulse.
A cardiac arrest is fatal and
2) CPR Initiation irreversible in minutes. Emergency
services should be called, and
Begin high-quality chest
CPR begun immediately.
compressions at 100-120/min.
Minimize interruptions.
3) Defibrillation Post-Cardiac Arrest Care
Apply AED as soon as available. Hemodynamic Optimization
Shock if ventricular fibrillation or
Maintain adequate blood pressure
pulseless VT.
and tissue perfusion. May require
4) Advanced Care vasopressors.
Establish IV access, give Targeted Temperature
epinephrine, and consider Management
advanced airway management.
Consider induced hypothermia for
comatose patients to improve
neurological outcomes.
How to spot the difference
between a heart attack and a Ventilation Management
cardiac arrest:
Optimize oxygenation and
Heart Attack Cardiac Arrest ventilation. Avoid hyperoxia and
hypocapnia.
Neurological Assessment
Conscious Unresponsive
Frequent neurological exams and
Breathing Not breathing consider EEG monitoring for
normally seizure activity.
Vice-like chest Irregular
pain heartbeat
Gerontological Considerations
in Heart Failure
Atypical Presentation
A heart attack may lead to a
cardiac arrest. Emergency Older adults may present with
non-specific symptoms like
confusion or weakness rather than  Care Coordination
typical heart failure symptoms.
Ensure communication between
Medication Management hospital, primary care, and
specialty providers.
Consider age-related changes in
pharmacokinetics and increased
risk of side effects.
Heart Failure Disease
Comorbidities Management Programs
Address multiple chronic  Clinic-Based Programs
conditions that often coexist with
Specialized heart failure clinics
heart failure in older adults.
providing comprehensive care and
Functional Assessment education.
Evaluate impact on activities of  Home-Based Programs
daily living and need for supportive
Nurse-led home visits for
services
assessment, education, and
medication management.
Transitional Care in Heart  Telemonitoring
Failure
Remote monitoring of symptoms.
 Discharge Planning vital signs, and weight to detect
early decompensation.
Begin early, addressing medication
reconciliation, follow- up
appointments, and home care
Quality Improvement in Heart
needs.
Failure Care
 Patient Education
Performance Measures: Track
Reinforce self-care skills, adherence to guideline-
medication management, and recommended therapies and
when to seek medical attention. patient outcomes.
 Follow-up Care Pathways: Implement
standardized protocols for heart
Schedule early post-discharge
failure management across care
follow-up, ideally within 7 days.
settings.
Consider phone calls within 48-72
hours. Team-Based Care: Foster
collaboration between cardiology,
primary care, nursing, and other
disciplines.
Patient Engagement: Involve
patients in shared decision-making
and self-management support.
Future Directions in Heart
Failure Management
 Novel Therapies
Research into new drug classes
and gene therapies for heart
failure treatment.
 Precision Medicine
Tailoring treatments based on
genetic profiles and biomarkers.
 Advanced Monitoring
Development of implantable
sensors for continuous
hemodynamic monitoring.
 Artificial Intelligence
Using Al to predict
decompensation and optimize
treatment strategies.
VASCULAR SYSTEM
The Vascular System Function of the Vascular System
The vascular system is a complex  Circulatory Needs
network of blood vessels that
Supplies oxygen and nutrients to
oxygen, nutrients, and waste
tissues based metabolic demands,
throughout the body.
Blood flow increases to tissues
It consists of veins and capillaries through vasodilation.
that work together to maintain
 Blood Pressure Regulation
blood flow and tissue perfusion.
Maintains blood pressure through
Understanding the anatomy and
and vasodilation of arterioles.
function of the vascular system is
Veins act as a reservoir.
crucial for nurses to effectively
assess and care for patients with  Fluid Exchange
vascular disorders.
Capillaries allow filtration and
reabsorption between blood and
interstitial space. Lymphatic
Anatomy of the Vascular
system drains excess fluid.
System
Arteries - Thick-walled vessels
that oxygenated blood from the Hemodynamics
heart to tissues. Composed intima,
1. Pressure Gradient: Blood
media, and layers. Larger arteries
flows from areas of high to low
have more elastic tissue to
Arterial pressure is higher than
accommodate blood flow.
venous pressure.
Veins - Thin-walled vessels that
2. Resistance: Opposes blood
return deoxygenated blood to the
flow, mainly from vessel
heart. Have valves to prevent
diameter. Arterioles are primary
backflow. Referred as capacitance
resistance vessels.
vessels due ability to hold large
blood volumes. 3. Flow: Rate of blood flow
depends on pressure gradient
Capillaries - Microscopic vessels
and resistance. Normally
that connect arteries and veins.
laminar can become turbulent.
Single cell layer thick to exchange
of nutrients and waste between
blood and tissues.
Regulation of Blood Flow Assessment of the Vascular
System
Neural Control: Sympathetic
nervous system causes Health History:
vasoconstriction. Decreased
 Assess for pain, claudication,
sympathetic activity leads to
rest pain, and risk factors.
vasodilation.
 Note onset, duration, and
Hormonal Factors: Epinephrine,
alleviating/aggravating factors.
angiotensin II, and other hormones
affect vascular tone. Can cause Physical Examination:
vasoconstriction or vasodilation.
 Inspect skin color, temperature,
Local Factors: Metabolites, pH and hair distribution.
changes, and oxygen influence
 Palpate pulses and note any or
local blood flow. Nitric oxide and
ulcerations.
prostaglandins cause vasodilation.
Diagnostic Tests: Order
appropriate tests like ABI, duplex
Pathophysiology of Vascular ultrasound, or angiography.
Disorders
Arterial Disorders
Ankle-Brachial Index (ABI)
Atherosclerosis, thrombosis, and
Measurement: Ratio of ankle
vasospasm can reduce blood May
systolic pressure to brachial
lead to tissue ischemia and
systolic pressure. Use Doppler to
necrosis if severe.
obtain pressures.
Venous Disorders
Calculation: Divide highest ankle
Thrombosis, valve incompetence, pressure by highest brachial
and muscle pump failure impair pressure.
venous return. Can cause edema
Normal ABI is 1.0-1.4.
and venous stasis
Interpretation: ABI <0.9 indicates
Lymphatic Disorders
peripheral artery. Lower values
Obstruction or damage to lymph suggest more severe
vessels leads to lymphedema.
Impairs fluid drainage from tissues
Doppler Ultrasound
Uses sound waves to detect Considerations: Requires
blood flow. Reflected signals iodinated contrast. May be
create audible sounds. contraindicated in renal
impairment. Radiation exposure is
Applications: Assesses arterial and
a concern.
venous blood flow. Used
measurements and detecting
occlusions.
Magnetic Resonance
Technique: Apply gel and position Angiography (MRA)
probe at 45-60 degree. Listen for
Uses strong magnetic fields to
characteristic arterial or venous
create detailed images of blood
Duplex Ultrasonography vessels. Can be done with or
without contrast.
B-Mode Imaging
Advantages: No radiation
Provides grayscale images of
exposure. Excellent soft tissue
vessels and surrounding
contrast. Can view vessels without
structures. Shows vessel anatomy
contrast in some cases.
and plaque.
Limitations: Contraindicated with
Color Flow
certain metal implants. Long scan
Displays direction and velocity of May overestimate degree of
blood flow in color. Helps identify stenosis.
stenosis or occlusions.
Conventional Angiography
Spectral Doppler
- Insert catheter into artery,
Measures blood flow velocities. usually femoral.
Waveforms indicate the degree of
- Inject iodinated contrast
stenosis disease.
through catheter. ray images
Computed Tomography taken as contrast flows
Angiography (CTA) vessels.

Technique: Injects contrast and Image Analysis: Evaluate vessel

uses CT to create detailed 3D anatomy, stenoses, and collateral
images of vessels. Rapid scan flow. Can perform interventions if
times with multidetector CT. needed.

Applications: Evaluates arterial Venography

stenosis, aneurysms, and vascular
Useful for surgical planning.
Inject contrast into peripheral vein. Ensure proper fasting if required.
X-rays taken as contrast through Assess for allergies and function.
veins. Rarely used now due to less Obtain informed consent.
invasive options
Monitoring
Indications: Diagnose deep vein
Observe for contrast reactions
thrombosis when ultrasound is
during and after procedures
inconclusive. Evaluate chronic
Monitor access sites for bleeding
venous insufficiency
or hematoma
Limitations: Invasive procedure.
Vascular Assessment in Older
Risk of contrast reactions and
Adults
Radiation exposure.
Age-Related Changes
Lymphoscintigraphy
Vessel walls stiffen and lose
Inject radioactive tracer
elasticity, Increased peripheral and
subcutaneously between toes or
left ventricular workload.
fingers. Patient exercises promote
lymph flow. Assessment Challenges
Imaging: Take serial images with Pulses may be difficult to palpate.
gamma camera as tracer moves Skin changes can mask signs of
through lymphatics. Can view ischemia. Comorbidities may
images immediately and delayed. complicate diagnosis.
- Assess lymphatic drainage Special Considerations
patterns and blockages or
Use Doppler for pulse
abnormalities in lymph flow
assessment. ABI may be falsely
elevated calcified vessels.
Consider toe-brachial index
Nursing Considerations for
Vascular Tests
Patient Education Arteriosclerosis and
Atherosclerosis
Explain procedure, purpose, and
what to expect. Address any Arteriosclerosis
concerns or questions.
Arteriosclerosis, or hardening of
Preparation the arteries, is the most common
arterial disease. It Involves
thickening of muscle fibers and
endothelial lining in small arteries Weakening of the arterial wall can
and arterioles. result in aneurysm formation.
Atherosclerosis
Atherosclerosis affects the intima
of large and medium- sized
Ulceration and Rupture
arteries. It involves accumulation
of lipids, calcium, blood Advanced atherosclerosis can
components, carbohydrates, and lead to ulceration and potential
fibrous tissue, forming atheromas rupture of the artery.
or plaques.
Consequences of
Relationship Atherosclerosis
While the processes differ,  Ischemia
arteriosclerosis and
Reduced blood flow leads to
atherosclerosis rarely occur in
inadequate oxygen and nutrient
isolation. The terms are often used
supply to tissues.
interchangeably. Atherosclerosis is
generalized and usually present  Necrosis
elsewhere when found in
Severe ischemia results in cell
extremities.
death (ischemic necrosis).
Pathophysiology of
 Fibrosis
Atherosclerosis
Dead cells are replaced by fibrous
Stenosis
tissue, which requires less blood
Atherosclerosis can lead to flow.
narrowing (stenosis) of the arterial
 Organ Dysfunction
lumen
Fibrosis and reduced blood supply
impair organ function over time.
Obstruction
Thrombosis can cause obstruction
Vulnerable Sites for
of the artery.
Atherosclerosis
Arterial Bifurcations
Aneurysm
Regions where arteries branch
into smaller vessels are
particularly susceptible to A matrix of collagen and elastic
atherosclerosis. fibers forms, contributing to plaque
development
Proximal Lower Extremity
Common sites include the distal
abdominal aorta, common iliac Types of Atherosclerotic
arteries, and superficial femoral Lesions
artery in the adductor canal.
Fatty Streaks
Lower Extremities
Yellow, smooth lesions that
Males tend to have more below- protrude slightly into the arterial
the- knee atherosclerotic lumen. Composed of lipids and
pathology compared to females. elongated smooth muscle cells.
Found in people of all ages,
Distal Lower Extremity
including infants. Usually does not
Atherosclerosis can occur cause clinical symptoms.
anywhere along the course of
Fibrous Plaques
arteries below the knee.
White to white-yellow lesions
composed of smooth muscle cells,
Reaction-to-Injury Theory of collagen fibers, plasma
Atherosclerosis components, and lipids.

Endothelial Injury Protrude into the arterial lumen,

sometimes completely obstructing
Vascular endothelial cells are
it. Found predominantly in the
damaged by factors like
abdominal aorta, coronary,
hemodynamic forces, Irradiation,
popliteal, and internal carotid
chemical exposure, or chronic
arteries.
hyperlipidemia.
Collateral Circulation in
Platelet and Monocyte Injury
Atherosclerosis
Aggregation of platelets and
Arterial Narrowing - Gradual
monocytes at the site.
narrowing of the arterial lumen due
Smooth Muscle Proliferation to atherosclerosis

Smooth muscle cells migrate and Collateral Development -

proliferate at the injury site. Stimulation of collateral circulation
from preexisting vessels
Matrix Formation
Blood Flow Rerouting - Increased Cardiovascular
Collateral vessels enlarge to Stress
reroute blood flow around stenosis
Nicotine increases heart rate and
or occlusion
blood pressure, causing
Tissue Perfusion - Continued vasoconstriction.
perfusion to tissues, but often
Clot Formation Risk
inadequate for Increased
metabolic demands Nicotine increases the risk of clot
formation by increasing platelet
Risk Factors for Atherosclerosis
aggregation.
Modifiable Risk Factors
Cholesterol Imbalance
 Nicotine use
Smoking decreases HDL (good
 Diabetes cholesterol) levels and alters ratios
between HDL, LDL, and
 Hypertension
triglycerides.
 Hyperlipidemia
 Diet
Diabetes and Atherosclerosis
 Stress
Increased Risk
 Sedentary lifestyle
Diabetes increases overall risk of
 Elevated C-reactive protein peripheral artery disease (PAD)
two- to fourfold.
 Hyperhomocysteinemia
Amputation Risk
Non-modifiable Risk Factors
Amputation rates are 5 to 10 times
 Increasing age
higher in patients with diabetes.
 Familial predisposition/genetics
Disease Progression
Patients with diabetes show earlier
Impact of Nicotine Use on onset and more rapid progression
Atherosclerosis of PAD.

Decreased Blood Flow Anatomic Distribution

Nicotine decreases blood flow to Diabetic patients exhibit greater

the extremities by stimulating the severity of disease in the profunda
sympathetic nervous system.
femoris and below- knee 3 Blood Pressure Control
segments.
Manage hypertension to reduce
risk of atherosclerosis progression.
Other Risk Factors for 4 Risk Factor Management
Atherosclerosis
Address multiple risk factors
Obesity simultaneously for maximum
benefit.
Excess weight strains the heart
and increases risk of
atherosclerosis.
Peripheral Artery Disease
Stress
Clinical Manifestations of
Chronic stress contributes to Peripheral Artery Disease
inflammation and vascular
 Intermittent Claudication
damage.
Aching, cramping, or fatigue in
Sedentary Lifestyle
muscles during activity, relieved by
Lack of exercise increases risk of rest.
atherosclerosis and related
 Decreased Walking Ability
conditions.
Reduced ability to walk the same
Inflammation
distance as before or increased
Elevated C-reactive protein pain with ambulation.
indicates increased cardiovascular
 Rest Pain
risk.
Persistent, aching pain associated
with critical ischemia of the distal
Prevention of Atherosclerosis extremity.
1 Diet Modification  Nocturnal Pain
Reduce fat intake, substitute Pain is often worse at night and
unsaturated for saturated fats, and may wake the patient
decrease cholesterol consumption.
2 Lipid-Lowering Medications
Assessment of Peripheral Artery
Statins and other medications may Disease
be prescribed to reduce blood lipid
Temperature Changes
levels.
Sensation of coldness or Risk Factor Modification
numbness in the extremities.
Smoking cessation, weight
Color Changes management, and control of
diabetes and hypertension.
Pale when elevated, ruddy or
cyanotic when dependent. Pharmacologic Therapy
Skin and Nail Changes Medications to improve blood flow
and reduce cardiovascular risk.
Ulceration, gangrene, and muscle
atrophy may be evident. Endovascular or Surgical
Intervention
Pulse Assessment
For severe cases or those
Peripheral pulses may be
unresponsive to conservative
diminished or absent.
management.
Diagnostic Tests for Peripheral
Pharmacologic Therapy for
Artery Disease
Peripheral Artery Disease
Ankle-Brachial Index (ABI) -
 Cilostazol -Phosphodiesterase
Compares blood pressure in ankle
III inhibitor that improves
to arm to assess arterial flow.
walking distance and reduces
Doppler Ultrasound - Uses pain.
sound waves to evaluate blood
 Antiplatelet Agents - Aspirin
flow in arteries.
or clopidogrel to prevent
Treadmill Testing - Assesses thromboemboli formation.
claudication and functional
 Statins - Improve endothelial
capacity during exercise.
function and may reduce
Imaging Studies - May include claudication severity
angiography, CT angiography, or
 Antihypertensives - Control
MR angiography to visualize
blood pressure to reduce risk
arterial anatomy
of cardiovascular events.
Medical Management of
Endovascular Management of
Peripheral Artery Disease
Peripheral Artery Disease
Supervised Exercise Therapy
Angioplasty - Balloon dilation of
Structured program to improve narrowed arteries
walking distance and reduce
claudication symptoms.
Stenting - Placement of metal Blood Volume
scaffolds to keep arteries open
Maintain adequate circulating
Atherectomy - Removal of plaque blood volume.
from artery walls
Drug-Eluting Devices - Release
Nursing Management:
medications to prevent restenosis
Monitoring Complications
Surgical Management of
Fluid Balance
Peripheral Artery Disease
Monitor urine output, central
Endarterectomy - Surgical
venous pressure, and vital signs.
removal of plaque from inside the
artery. Bleeding
Bypass Grafting - Creation of a Assess for hematoma formation or
new route for blood flow around anastomotic leaks.
blocked arteries.
Thrombosis
Graft Selection - Choice between
Prevent by avoiding leg crossing
synthetic materials or autologous
and prolonged dependency.
vein grafts.
Edema
Amputation - In severe cases
where revascularization is not Elevate extremities and encourage
possible or unsuccessful exercise to reduce swelling.
Nursing Management: Nursing Management:
Maintaining Circulation Discharge Planning
Pulse Assessment Activities of Daily Living
Monitor pulses, color, temperature, Assess patient's ability to manage
and capillary refill of affected Independently.
extremity.
Support Network
Doppler Evaluation
Determine availability of family and
Use Doppler to assess vessels friends to assist.
distal to bypass graft.
Lifestyle Changes
Ankle-Brachial Index
Educate on pain management,
Monitor ABI at regular intervals diet, activity, and skin care.
postoperatively.
Complication Awareness Angioplasty with possible stent
placement for focal lesions.
Teach signs of infection, graft
occlusion, and decreased blood 3 Surgical Bypass
flow.
For subclavian artery lesions with
 Upper Extremity Arterial intracranial blood flow siphoning
Disease
4 Postoperative Care
Causes: Atherosclerosis or
Monitoring of arm position, pulses,
trauma to upper extremity arteries.
and blood flow.
Symptoms:
 Aortoiliac Disease
 Arm fatigue,
Symptoms:
 pain with exercise,
 Buttock or low back discomfort
 difficulty grasping objects, with walking,
and
 possible erectile dysfunction in
 possible vertebrobasilar men.
symptoms.
Treatment Options
Assessment:
Endovascular procedures or
 Coolness, surgical bypass grafting.

 pallor, Physical Findings

 decreased capillary refill, Decreased or absent femoral

and pulses.

 significant difference in arm Surgical Approach

blood pressure.
Aortoiliac or aortobifemoral bypass
grafting using Dacron grafts.

Management of Upper Extremity

Arterial Disease
Nursing Care for Aortoiliac
1 Diagnostic Imaging Disease

Duplex ultrasonography and Preoperative Assessment

possibly arteriography.
Evaluate pulses in upper and
2 Endovascular Procedure lower extremities to establish
baseline.
Patient Education threatening complications if left
untreated.
Provide overview of procedure,
preparation, and postoperative
expectations.
Postoperative Monitoring
Types of Aneurysms
Assess for signs of thrombosis,
 Saccular Aneurysm
monitor urine output, and check for
bowel sounds A saccular aneurysm projects from
only one side of the vessel,
Complication Watch
forming a bulbous protrusion.
Be alert for signs of renal
 Fusiform Aneurysm
impairment, paralytic ileus, or
bowel ischemia. A fusiform aneurysm involves the
dilation of an entire arterial
Long-Term Management of
segment, creating a symmetric,
Arterial Disorders
spindle-shaped expansion.
Regular Exercise
 Mycotic Aneurysm
Encourage participation in
Very small aneurysms caused by
supervised exercise programs to
localized infection are called
improve circulation.
mycotic aneurysms.
Healthy Diet
Promote a balanced diet low in
Causes of Aneurysms
saturated fats and cholesterol.
Atherosclerosis
Smoking Cessation
The most common cause of
Support efforts to quit all forms of
abdominal aortic aneurysms is
tobacco use.
atherosclerotic changes in the
Medication Adherence aorta.
Genetic Factors
Understanding Aneurysms and Congenital disorders like Marfan
Vascular Disorders syndrome and Ehlers-Danlos
syndrome can lead to aneurysm
Aneurysms and vascular disorders
formation.
are serious conditions affecting the
blood vessels that can lead to life- Infections
Bacterial, fungal, or spirochetal Treatment includes controlling
infections can cause infectious blood pressure and correcting risk
(mycotic) aneurysms. factors. Beta-blockers and
angiotensin receptor blockers
Trauma
(ARBs) are commonly used
Penetrating or blunt arterial medications.
injuries can result in traumatic
Surgical Repair
aneurysms (pseudoaneurysms).
The goal of surgery is to repair the
aneurysm and restore vascular
 Thoracic Aortic Aneurysms continuity with a vascular graft.

Causes: Endovascular Repair

caused by atherosclerosis, Endovascular grafts placed

occurring most frequently in men percutaneously may decrease
between 50-70 years old. postoperative recovery time and
complications compared to
Symptoms:
traditional surgical techniques.
 Pain is the most prominent
 Abdominal Aortic Aneurysms
symptom,
Risk Factors
 along with dyspnea,
Abdominal aortic aneurysms affect
 cough,
men 2-6 times more often than
 hoarseness, and women, are more common in
White versus Black men, and are
 dysphagia due to pressure on
most prevalent in patients older
surrounding structures.
than 65 years.
Diagnosis:
Symptoms
Diagnosis is made primarily
Only about 40% of patients have
through chest x-ray, computed
symptoms, which may include
tomography angiography (CTA),
feeling a pulsating mass or
MRA, or transesophageal
abdominal throbbing. Severe back
echocardiography (ΤΕΕ).
or abdominal pain may indicate
Treatment of Thoracic Aortic impending rupture.
Aneurysms
Diagnosis
Medical Management
Diagnosis is made through sites for bleeding or hematoma
physical examination, duplex formation.
ultrasonography, or CTA to
Patient Education
determine the size, length, and
location of the aneurysm. Instruct patients on activity
restrictions, signs of complications
Treatment of Abdominal Aortic
to report, and the importance of
Aneurysms
follow- up care.
Medical Management
Complication Prevention
Blood pressure is closely
Implement measures to prevent
monitored and controlled using
pressure injuries and maintain
antihypertensive agents to reduce
proper positioning of the affected
the risk of rupture.
limb.
Endovascular Repair
 Aortic Dissection
Endovascular aortic repair
Aortic dissection occurs when a
involves the transluminal
tear develops in the intima or the
placement of a sutureless aortic
media degenerates, resulting in
graft across the aneurysm, often
separation of the aortic wall layers.
performed under local or regional
anesthesia. Risk Factors:
Surgical Repair  poorly controlled
hypertension,
Open surgical repair may be
necessary for complex cases or  blunt chest trauma, and
when endovascular repair is not
 cocaine use.
suitable.
Symptoms:
Nursing Management for
Aneurysm Patients  Sudden onset of severe,
persistent pain described as
Preoperative Assessment
tearing or ripping, often in
Assess for signs of rupture and the chest or back and
evaluate cardiovascular, cerebral, extending to other areas.
pulmonary, and renal function.
Diagnosis:
Postoperative Monitoring
Diagnosis may Involve
Frequently monitor vital signs, arteriography, MDCTA, TEE,
peripheral pulses, and access duplex ultrasonography, or MRA.
 Embolectomy - Emergency
embolectomy using a balloon-
 Arterial Embolism and
tipped catheter is the procedure of
Thrombosis
choice for viable limbs.
Arterial Embolism
Thrombolytic Therapy
Emboli commonly arise from
Intra-arterial thrombolytic
thrombi in the heart chambers,
medications may be used to
often due to atrial fibrillation or
dissolve the embolus when
other cardiac conditions.
appropriate.
Arterial Thrombosis
Endovascular Techniques
Thrombosis is a slowly developing
Percutaneous mechanical
clot that usually occurs where the
thrombectomy devices may be
arterial wall has been damaged,
used for acute thrombosis
often due to atherosclerosis.
treatment.
Symptoms:
The six Ps of acute arterial
Nursing Care for Arterial
occlusion:
Occlusions
 pain,
Positioning
 pallor,
Keep the affected extremity level
 pulselessness, or slightly dependent (15 degrees)
and at room temperature.
 paresthesia,
Monitoring
 poikilothermia, and
Assess pulses, Doppler signals,
 paralysis.
ABI, and motor and sensory
function frequently.

Treatment of Arterial Occlusions Bleeding Precautions

Immediate Anticoagulation Minimize punctures and apply

prolonged pressure after any
Heparin therapy is initiated to
necessary procedures.
prevent further emboli
development and thrombi Patient Education
extension.
Instruct on activity levels and signs Management of Raynaud's
of complications to report Phenomenon
immediately.
Trigger Avoidance
 Raynaud's Phenomenon
Avoiding cold exposure and stress
Primary Raynaud's is crucial in controlling symptoms.
Idiopathic form occurring in the Medication
absence of underlying disease.
Calcium channel blockers may be
Secondary Raynaud's effective in relieving symptoms.
Associated with underlying Lifestyle Changes
conditions like connective tissue
Quitting smoking and avoiding
disorders or obstructive arterial
sympathomimetic medications are
lesions.
important.
Prevalence
Surgical Intervention
Five times more common in
Sympathectomy may help some
women, with typical onset before
patients in severe cases.
age 30

 Acrocyanosis
Clinical Manifestations of
Raynaud's Characteristics:
 Pallor  Persistent skin color changes,
symmetry, and
Initial whiteness of affected digits
due to sudden vasoconstriction.  absence of paroxysmal pallor
distinguishes it from
 Cyanosis
Raynaud's.
Bluish discoloration caused by
Associated Symptoms:
pooling of deoxygenated blood
during vasospasm.  Marked clamminess and
 Rubor  hyperhidrosis of hands and
feet, worsening in warmer
Redness resulting from hyperemia
temperatures.
as oxygenated blood returns after
vasospasm stops. Treatment
  Focus on avoiding cold Venous thromboembolism (VTE)
exposure and trauma and encompasses deep vein
thrombosis (DVT) and pulmonary
 Improving local circulation.
embolism (PE).
Calcium channel blockers
are not effective Deep vein thrombosis (DVT)
DVT refers to blood clot formation
in deep veins, usually in the legs.
Patient Education for Raynaud's
and Acrocyanosis Pulmonary embolism (PE).
Cold Protection PE occurs when a clot travels to
and obstructs pulmonary arteries.
Wear layers of clothing, hats, and
gloves when outdoors. Use VTE has an annual incidence of 1-
specially designed fabrics for cold 2 per 1000 population and affects
climates. 10-20% of general medical
patients and up to 80% of critically
Lifestyle Modifications
ill patients.
Avoid all forms of nicotine and
It is often asymptomatic and
manage stress through relaxation
undiagnosed, with 30% of patients
techniques
developing long-term
Precautions complications.

Handle sharp objects carefully to Most symptomatic cases in

avoid injuring fingers. Be aware of surgical patients occur after
orthostatic hypotension from hospital discharge due to shorter
medications. stays.

Reassurance
Educate patients that serious
complications like gangrene are
uncommon unless there's an
underlying arterial occlusive
disease.

Venous Thromboembolism:
Deep Vein Thrombosis and
Pulmonary Embolism
 HYPERTENSION
Blood Pressure Resistance
The amount of resistance of blood Risk Factors
pumping through the
Modifiable risk factors include:
body/arteries.
 Smoking
Persistent High Blood Pressure
 alcohol use
Persistent or intermittent high
blood pressure in which the  lack of physical activity,
systolic is above 140 mmHg & the and
diastolic pressure is above 90
 unhealthy diet.
mmHg (> 140/90 mmHg).
Non-modifiable risk factors
Major Health Risks
include:
Major causes of heart failure,
 age
kidney failure, and stroke.
 genetics and
Silent Killer
 race
HTN is known as the SILENT
KILLER Nursing Interventions
Symptoms  Monitor vital signs, including
blood pressure, heart rate,
Hypertension is often called the
heart rate, and respiratory rate.
"silent killer" because it often has
no symptoms.  Assess for signs and
symptoms of hypertensive
However, some people may
crisis, such as headache,
experience symptoms such as:
blurred vision, and chest pain.
 Severe headache
 Administer medications as
 Nosebleeds ordered, such as
antihypertensive drugs,
 Dizziness
diuretics, and vasodilators.
 Fatigue
Treatment Steps
 Vision changes
 Chest pain
 Difficulty breathing
Treatment for hypertension is a Additionally, managing stress
multi-faceted approach. It involves levels and avoiding smoking and
lifestyle modifications, medication, excessive alcohol consumption
and regular monitoring. are essential for preventing
hypertension.
Lifestyle changes include dietary
adjustments, regular exercise, and Major Risk Factors
stress management.
 Cardiac System
Medications are prescribed based
Hypertension can damage the
on the severity of hypertension
heart, leading to heart attacks,
and individual patient factors.
strokes, and heart failure.
Medications
 Kidneys
Medications are used to manage
Hypertension can damage the
hypertension. They are prescribed
kidneys, leading to kidney failure.
based on the patient's individual
needs and risk factors. The goal of  Brain
treatment is to lower blood
High blood pressure can damage
pressure to a safe level and
blood vessels in the brain, leading
prevent complications.
to strokes and dementia.
Regular monitoring of blood
 Eyes
pressure is crucial to assess the
effectiveness of treatment and High blood pressure can damage
make adjustments as needed. blood vessels in the eyes, leading
to vision loss.
Prevention
Prevention of hypertension is
crucial for maintaining overall NEURAL THEORY
health and well-being.
 Neural Theory
Lifestyle modifications play a
An abnormal condition in which
significant role in reducing the risk
excessive neurohumoral
of developing hypertension. These
stimulation results in increased
modifications include adopting a
muscle tone.
healthy diet, engaging in regular
physical activity, and maintaining a  Sympathetic Nervous
healthy weight. System Activation
Increased CNS activity could raise aldosterone, a hormone that
BP by increasing renin via the promotes sodium and water
release of release of retention, further increasing blood
catecholamines, or by causing volume and blood pressure
veno-arterial constriction.
Vasopressor
constriction.
Decreases the concentration of
 Baroreceptors
vasodilating substances such as
Are a type of mechanoreceptors prostaglandins & kinins.
allowing for relaying information
While the exact cause is not
derived from blood pressure within
known, several factors have been
the autonomic nervous system.
identified as contributing factors to
system.
the development of hypertension.
 Renin-Angiotensin-
Primary/Essential Hypertension
Aldosterone System
The cause of primary hypertension
Stimulation & production of high
is unknown
plasma levels of renin results in
the production of angiotensin I & II. Risk Factors
 Angiotensin II  Race
Angiotensin II stimulates  Increased Sodium or Alcohol
aldosterone resulting in sodium & Intake
water retention.
 Smoking/Stress
Visual Representation of RAAS
 Low Potassium and Vitamin D
The renin-angiotensin-aldosterone Levels
system (RAAS) is a complex
 Family History
hormonal system that plays a vital
role in regulating blood pressure  Advanced Age
and fluid balance. The RAAS is
 High Cholesterol
activated when there is a decrease
in blood pressure or blood volume.  Excessive Caffeine
volume. This activation leads to
 Obesity
the production of angiotensin II, a
potent vasoconstrictor that  Restricted Activity
increases blood pressure.
 Sleep Apnea
pressure. Angiotensin II also
stimulates the release of
Secondary Hypertension history are essential to identify
potential risk factors and
is a condition where high blood
contributing factors.
pressure is caused by an
underlying medical condition. Pre-  Retinal Examination and
existing Issues Laboratory Studies
Conditions that can cause Retinal examination can reveal
secondary hypertension include signs of hypertensive retinopathy,
pregnancy, Cushing syndrome, while laboratory studies help
chronic renal failure, diabetes, assess kidney function and other
hypo/hyperthyroidism, organ systems.
pheochromocytoma, coarctation of
 Urinalysis and
the aorta, and medications.
Electrocardiogram
Malignant Hypertension
Urinalysis can detect proteinuria, a
is a severe form of hypertension sign of kidney damage, while an
that causes damage to arterioles ECG can identify any cardiac
and arteries because of sustained abnormalities.
high blood pressure.
Nursing Interventions for
Hypertensive crisis Hypertension
is a severe form of hypertension Assess: Measure blood pressure,
that can cause acute impairment ask about family history, if any
of organ systems. sensory changes.
Evaluate: Blood pressure reading,
dietary intake, body mass index
Nursing Assessment of
(overweight).
Hypertension
Educate: Limiting sodium, alcohol
 Diagnostic Evaluation
and caffeine in diet, quit smoking,
A comprehensive assessment is exercise, medication compliance,
crucial for accurate diagnosis and measuring blood pressure.
diagnosis and management of
MEDICAL MANAGEMENT
hypertension.
Objective: To prevent associated
 Physical Examination and
morbidity and mortality by
Health History
achieving and maintaining arterial
A thorough physical examination BP below 140/90 mmHg whenever
and detailed health history are possible.
The Step-Care Approach Examples: Chlorothiazide.,
Chlorthalidone,
Step 0: Non-pharmacologic
Hydrochlorothiazide, Indapamide,
approaches.
Metolazone.
Non-Pharmacologic Approaches :
Important Considerations
 Sodium restriction
1. Monitor BUN and creatinine
 Weight control levels

 Alcohol restriction 2. Not for patients in renal failure.

 Risk factor control 3. Watch patients taking Lithium

(increases Lithium toxicity).
Antihypertensive Drugs
4. Thiazides waste potassium.
Carbonic anhydrase inhibitor:
Educate patients about
 Acetazolamide potassium supplement
compliance and
 Brinzolamide
photosensitivity.
 Dorzolamide
Loop diuretic can cause
Osmotic Diuretics
hypokalemia. (Diuretics continued)
Osmotic Diuretics are used to treat
 Bumetamide
conditions such as cerebral
 Furosemide edema, glaucoma, glaucoma, and
acute renal failure.
Diuretics
Examples: Isosorbide dinitrate,
Drugs that increase the excretion
Isosorbide mononitrate, Mannitol
of sodium and water from the
kidney. They affect blood sodium ACE Inhibitors (Angiotensin-
levels and blood volume. Often the Converting Enzyme Inhibitors):
first agents tried in mild
hypertension. These drugs
increase urination and can disturb
electrolyte and acid-base balance.
Thiazide Diuretics
Thiazide diuretics work by
removing water and sodium
through the kidneys.
Block the conversion of place of ACE inhibitors if patient
angiotensin I to angiotensin II, a can't tolerate ACE Inhibitor)
potent vasoconstrictor. This stops
Side Effects:
the phase of renin-angiotensin
system before vasoconstriction Same side effects as ACEI (except
can occur or aldosterone can be dry cough) & Increase k+ level.
released. This action leads to a
 Angiotensin II receptor
decrease in blood pressure and in
blockers (ARBs) selectively
aldosterone secretion.
bind to the angiotensin II
Administration: receptors.
They should be taken on an empty  Prevention ARBs prevent
stomach (1 hour before or 2 hours vasoconstriction in blood
after meals). meals). vessels by blocking the
angiotensin II receptors.
Side Effects:
 ARBs prevent the release of
 Educate pt about dry
aldosterone in the adrenal
cough/taste changes.
cortex by blocking the
 Avoid potassium substitutes or angiotensin II receptors.
supplements. This drug causes receptors.
potassium retention.
Dosage:
Effects of ARBS:
 Captopril - Increased risk of
 These actions lead to a
bleeding
decrease in blood pressure
 Moexipril -. take 1 hour caused by a decrease in total
BEFORE a meal or 2 hours peripheral resistance and blood
after meal. volume.
ARBS (Angiotensin Receptor  Common ARBS
Blockers)
- Candesartan
Works by causing vasodilation by
- Irbesartan
blocking aldosterone and
Angiotensin. - Losartan
ARBS Drugs that end in "sartan" - Olmesartan
ex: Losartan (may be prescribed in
- Telmisartan
 - Valsartan BB: Beta Blockers
Beta blockers affect epinephrine
and norepinephrine, blocking the
CCB (Calcium Channel Blockers
sympathetic nervous system of the
Slow the heart rate to decrease heart.
the workload on the heart and
This keeps the heart rate low and
cause vasodilation which lowers
low and dilates vessels, lowering
blood pressure.
blood pressure.
Prevent the movement of calcium
Contraindications:
into cardiac and smooth muscle
cells when the cells are stimulated,  Not for patients with asthma or
COPD because this medication
Effect on Muscle Cells: Interferes
blocks receptors in the lungs,
with muscle cell's ability to
causing bronchoconstriction.
contract, leading to a loss of
smooth muscle tone, vasodilation Monitoring:
and decrease peripheral
 Monitor glucose levels in
resistance.
diabetics because it conceals
Watch for bradycardia. the signs of hypoglycemia.
Contraindications: Watch pts  Monitor heart rate and for
who have CHF or AV blocks. orthostatic hypotension.

Effects of Calcium Channel Vasodilators

Blockers
Produce relaxation of the vascular
 Decrease blood pressure, smooth muscle, decreasing the
cardiac workload, and peripheral resistance and
myocardial oxygen resistance and reducing the BP.
consumption.
Most vasodilators are reserved for
 They are very effective in the use in severe HTN or hypertensive
treatment of angina because emergencies.
they decrease cardiac
workload.
Step-Care Approach
 Not all calcium channel
blockers are used to treat Step 1. Use of diuretic or Ca
hypertension. antagonist or ACE inhibitor.
Step 2. Addition of 2nd drug of 3. Dizzy
different class or increase the dose
4. Nausea/Vomiting
of the dose of the first drug or
substitute the first drug with 5. Confusion/ALOC
another class of drugs.
6. Coma
Step 3. Add 3rd drug of different
7. CP/SOB
class or substitute the second drug
with another class. 8. SZ - Encephalopathy, ICH,
SAH
Step 4. Further evaluation &/or
referral or add a third drug/fourth 9. Heart Failure, Pul. Edema
drug.
10. Aortic dissection
The Step-Down Approach
11. Renal failure
1. Reduce Dosage If BP is
12. MI
controlled
13. Retinopathy
2. Discontinue Drug If BP
remains controlled RF:
3. Monitor BP After each 1. Hx. of HPN
change
2. Drug abuse
3. Pre-eclampsia
4. Drug MAO inhibitor - used in
HYPERTENSIVE CRISIS mental health setting
is defined as a systolic blood 5. Head injury
pressure of greater than 180
6. Acute aortic dissection
and/or a diastolic blood pressure
of greater than 120. Death can be
caused by stroke, renal failure, or
cardiac disease.
Signs and Symptoms
Treatment
S/s:
Hospitalization: IV medications
1. Diastolic above 120
with titration.
2. Headache
Titrate Medications: Titrate
medications to mean arterial
pressure (MAP).
Cardiac Monitoring: Continuous
cardiac monitoring is essential.
MAP Calculation: MAP = SBP + (2
x DBP) / 3
Normal MAP=70-110 mmHg

Nursing Interventions
 Maintain a Patent Airway
Ensure the patient's airway is open
and clear.
 Monitor BP and HR
Monitor blood pressure and heart
rate every 5-10 minutes.
 Goal Titration
Gradually decrease mean arterial
pressure (MAP) by (MAP) by 20-
25% over 24 hours.
 Assess for Hypotension
Monitor for signs of hypotension
and place the patient in a supine
position if necessary.
Understanding Shock  Vasogenic (Blood Vessel)
Shock is a critical medical Shock caused by changes in blood
condition characterized by vessel tone or permeability, often
Inadequate blood circulation, seen in septic or anaphylactic
resulting in insufficient tissue shock.
perfusion and potential organ
 Cardiogenic (Heart)
failure.
Shock resulting from the heart's
Shock is a state of ineffective
inability to pump blood effectively,
blood circulation in the body,
often due to myocardial infarction
leading to Inadequate tissue
or heart failure
perfusion and potential vital organ
shutdown.
Normal circulatory homeostasis is Factors Regulating Circulatory
maintained by the continuous flow Homeostasis
of blood throughout the body's
Preload
systems.
The degree of stretch of cardiac
In shock, this homeostasis is
muscle fibers at the end of
compromised, leading to a
diastole, determined by the
reduction in effective circulating
volume of blood within the
blood volume and potential organ
ventricle.
dysfunction.
Ventricular Contraction
The strength of the heart's
Blalock's Classification of
contraction, influenced by preload
Shock
and following the Frank-Starling
 Hematogenic (Blood) Law of the heart.
Shock caused by blood loss or Afterload
alterations in blood composition,
The resistance to blood ejection
such as severe anemia or
from the ventricle, primarily
coagulation disorders.
determined by arterial pressure
 Neurogenic (Nervous) and vascular resistance.
Shock resulting from disruption of
the nervous system's control over
blood vessels, leading to
vasodilation and blood pooling. Preload: The Stretching Force
Preload refers to the degree of The stronger contraction results in
stretch of cardiac muscle fibers at a greater stroke volume, ejecting
the end of diastole, directly more blood from the ventricle.
influenced by the volume of blood
Improved Cardiac Output
within the ventricle.
The increased stroke volume
Importance: Preload plays a
leads to an overall improvement in
crucial role in determining the
cardiac output, enhancing
strength of ventricular contraction,
circulation.
following the Frank-Starling Law of
the heart. Afterload: Resistance to
Ejection
Measurement: Preload can be
clinically estimated through central Afterload is the resistance that the
venous pressure (CVP) ventricle must overcome to eject
measurements or blood, primarily determined by
echocardiographic assessment of arterial pressure and vascular
ventricular end-diastolic volume. resistance.
Clinical Implications: Changes in Major components include
preload can significantly affect systemic vascular resistance,
cardiac output, making it a critical blood viscosity, and the elastic
factor in managing patients with properties of the arterial walls.
shock or heart failure.
Clinical Significance
Ventricular Contraction and the
Increased afterload can
Frank-Starling Law
significantly reduce cardiac output
Initial Stretch and strain the heart, potentially
leading to or worsening heart
As blood returns to the heart,
failure.
cardiac muscle fibers stretch,
increasing preload. Management
Enhanced Contraction Medications like vasodilators can
be used to reduce afterload in
The stretched muscle fibers
certain clinical scenarios,
contract more forcefully, following
improving cardiac function and
the Frank-Starling Law.
tissue perfusion
Increased Stroke Volume

Hypovolemic Shock
is characterized by a marked 3. Tissue Hypoxia
decrease in circulating blood
As shock progresses, inadequate
volume, leading to inadequate
tissue perfusion leads to cellular
tissue perfusion.
hypoxia and metabolic acidosis.
Clinical Threshold: Shock
4. Organ Dysfunction
typically occurs when there's a
reduction in intravascular volume Prolonged hypoperfusion results in
of 15% to 25%, equivalent to 750- organ dysfunction, potentially
1,300 mL of blood loss in a 70kg leading to multiorgan failure if not
adult. addressed promptly.
Common causes include:
 traumatic blood loss, Clinical Assessment of
Hypovolemic Shock
 severe dehydration,
 Mental Status
 extensive burns, and
Patients may appear restless and
 excessive fluid shifts within the
apprehensive, progressing to
body.
confusion or decreased
Primary Goal Treatment consciousness as shock worsens.

focuses on restoring blood volume  Skin Signs

through fluid replacement and
Look for pale, cool, and clammy
addressing the underlying cause
skin, Indicating peripheral
of volume loss.
vasoconstriction and decreased
Pathophysiology of perfusion.
Hypovolemic Shock
 Vital Signs
1. Initial Volume Loss
Tachycardia, hypotension, and
Blood or fluid loss reduces tachypnea are common. Note that
circulating volume, decreasing bradycardia is an ominous sign in
venous return and cardiac output late-stage shock
2. Compensatory Mechanisms
The body responds with
vasoconstriction and increased
 Urine Output
heart rate to maintain blood
pressure and perfusion.
Monitor for oliguria, defined as effectively, leading to inadequate
urine output less than 0.5 tissue perfusion despite adequate
mL/kg/hour in adults, indicating blood volume.
renal hypoperfusion.
Common causes include:
Nursing Interventions for
 myocardial infarction,
Hypovolemic
 severe arrhythmias,
Airway and Oxygenation
 cardiomyopathies, and
Ensure a patent airway and
administer oxygen as ordered to  mechanical complications
improve tissue oxygenation. like valve rupture.
Fluid Resuscitation Hemodynamics
Prepare and administer IV fluids, Typically characterized by low
colloids, or blood products as cardiac output, high peripheral
ordered to restore intravascular vascular resistance, and elevated
volume. central venous pressure.
Monitoring Treatment Goal
Continuously assess vital signs, The primary aim is to improve
urine output, and mental status to cardiac function and maintain
evaluate response to treatment adequate tissue oxygenation and
and detect complications. perfusion.
Hemodynamic Support Pathophysiology of Cardiogenic
Shock
Be prepared to administer
vasopressors if fluid resuscitation 1. Initial Cardiac Insult
alone is insufficient to maintain
Myocardial damage or dysfunction
adequate perfusion.
leads to decreased contractility
and reduced cardiac output
2. Compensatory Mechanisms
The body responds with increased
sympathetic activity, causing
Cardiogenic Shock:
tachycardia and vasoconstriction.
Understanding the Failing Heart
3. Vicious Cycle
Cardiogenic shock occurs when
the heart fails to pump blood
Reduced coronary perfusion Ensure adequate oxygenation,
further impairs myocardial prepare for possible intubation,
function, exacerbating the shock and assist with medication
state. administration as ordered.
4. Systemic Effects Hemodynamic Monitoring
Prolonged hypoperfusion leads to Assist with invasive monitoring
multi-organ dysfunction, metabolic setup, such as arterial lines or
acidosis, and potentially Swan-Ganz catheters, to guide
Irreversible shock. therapy.
Clinical Assessment of Pharmacological Support
Cardiogenic Shock
Prepare and administer
 Vital Signs vasopressors, inotropes, and other
cardiac medications as prescribed.
 Look for hypotension
(systolic BP <90 mmHg), Mechanical Support
 tachycardia, and Assist in preparing the patient for
mechanical circulatory support
 signs of respiratory distress.
devices if needed, such as intra-
 Perfusion Signs aortic balloon pumps

Assess for cold, clammy skin,

delayed capillary refill, and weak
Neurogenic Shock: When
peripheral pulses.
Nerves Fail
 Cardiac Symptoms
Neurogenic shock results from a
Note any ongoing chest pain, disruption in the autonomic
dyspnea, or signs of pulmonary nervous system, leading to loss of
edema sympathetic tone and subsequent
vasodilation.
 Neurological Status
Common Causes:
Monitor for altered mental status,
ranging from anxiety and  Spinal cord injuries, especially
confusion to lethargy. those above T6, are the most
frequent cause.
Nursing Interventions for
Cardiogenic Shock  Other causes include severe
head injuries and certain
Immediate Stabilization
medications.
Pathophysiology Immediate Actions
Loss of sympathetic stimulation Maintain spinal immobilization,
leads to widespread vasodilation ensure adequate oxygenation, and
and venous pooling, reducing prepare for possible intubation in
venous return and cardiac output. high cervical injuries.
Unique Feature Hemodynamic Management
Unlike other forms of shock, Administer IV fluids as ordered
neurogenic shock often presents and prepare vasopressors to
with bradycardia due to combat hypotension. Monitor
unopposed vagal tone. response closely.
Clinical Presentation of Bradycardia Management
Neurogenic Shock
Be prepared to administer atropine
Hypotension is a hallmark sign, or initiate pacing for severe
often accompanied by bradycardia as per physician
bradycardia, which distinguishes it orders.
from other forms of shock.
Ongoing Care
 Skin Signs
Implement prevent complications
Patients may present with warm, such as deep vein.
dry skin below the level of injury
due to loss of sympathetic tone.
Septic Shock: When Infection
 Neurological Symptoms
Overwhelms
Look for signs of spinal cord injury
Septic shock is a life-threatening
such as paralysis, loss of
condition caused by a
sensation, or priapism in male
dysregulated host response to
patients.
infection, leading to circulatory,
 Associated Symptoms cellular, and metabolic
abnormalities.
Patients may experience
respiratory difficulties, especially Pathophysiology
with high cervical spine injuries
Bacterial toxins trigger a massive
affecting diaphragm innervation.
inflammatory response, leading to
Nursing Interventions for widespread vasodilation,
Neurogenic Shock increased vascular permeability,
and myocardial depression.
Common Causes: Leukocytosis or leukopenia,
thrombocytopenia, elevated
While various pathogens can
inflammatory markers, and
cause sepsis, gram-negative
metabolic acidosis are common.
bacteria are the most frequent
culprits. Common sources include Nursing Management of Septic
urinary tract, respiratory, and Shock
abdominal infections.
Early Recognition
Clinical Progression
Promptly identify signs of sepsis
Sepsis can rapidly progress from and alert the medical team to
systemic inflammatory response initiate early goal-directed therapy.
syndrome (SIRS) to severe sepsis
Fluid Resuscitation
and ultimately septic shock if not
promptly addressed. Administer crystalloid fluids as
ordered, typically 30 mL/kg within
Recognizing Septic Shock:
the first 3 hours, while monitoring
Clinical Presentation
for signs of fluid overload.
 Early Signs
Antibiotic Administration
Fever or hypothermia, tachycardia,
Prepare and administer broad-
tachypnea, and altered mental
spectrum antibiotics within one
status are common early
hour of sepsis recognition, after
indicators of sepsis.
obtaining appropriate cultures.
 Hemodynamic Changes
Ongoing Monitoring
Initially, patients may present with
Continuously assess vital signs,
warm, flushed skin due to
urine output, mental status, and
vasodilation. As shock progresses,
laboratory values to guide further
hypotension and signs of poor
interventions and evaluate
perfusion develop.
treatment response.
 Organ Dysfunction
Look for signs of organ
Anaphylactic Shock: A Severe
dysfunction such as oliguria,
Allergic Response
elevated lactate levels,
coagulopathy, or acute lung injury. Anaphylactic shock is a severe,
potentially life-threatening allergic
 Laboratory Findings
reaction characterized by rapid
onset and multisystem  stridor, and
involvement.
 upper airway edema are
Common causes include: common and can rapidly
progress to respiratory
 foods (e.g., nuts, shellfish),
failure.
 medications (e.g., antibiotics,
 Cardiovascular Signs
NSAIDs),
 Tachycardia is common,
 insect stings, and
followed by hypotension.
 latex. Patients may report
dizziness, syncope, or
Pathophysiology: Allergen
chest pain.
exposure triggers massive release
of inflammatory mediators, leading  Gastrointestinal Symptoms
to vasodilation, increased vascular
 Nausea,
permeability, and bronchospasm.
 vomiting,
Rapid Progression
 abdominal pain, and
Symptoms can develop within
minutes of exposure and can  diarrhea may occur,
progress rapidly to life-threatening especially in food-induced
shock if not promptly treated. anaphylaxis.
Recognizing Anaphylactic Emergency Management of
Shock: Clinical Presentation Anaphylactic Shock
 Skin and Mucosal Symptoms Immediate Actions
 Look for generalized Remove the allergen if possible.
urticaria, Position the patient flat with legs
elevated unless respiratory
 angioedema,
distress is present.
 flushing, and
Epinephrine Administration
 pruritus. These are present
Administer intramuscular
in up to 90% of cases.
epinephrine (0.3-0.5m 5mg of
 Respiratory Symptoms 1:1000 solution) in the
anterolateral thigh. Repeat every
 Dyspnea,
5- 15 minutes if needed.
 wheezing,
Airway Management
 Provide supplemental oxygen and Differential Diagnosis in Shock
prepare for possible intubation if States
upper airway edema progresses.
Shock Key Features Distinguishing
Fluid Resuscitation
Type Factors
Administer large volumes of IV
Hypo- History of fluid Improved with
crystalloids to combat
volemic loss, cold fluid
intravascular volume depletion
extremities resuscitation
from Increased vascular
permeability. Cardio- History of Elevated
Monitoring and Secondary genic cardiac jugular
Treatment in Anaphylaxis disease, venous
pulmonary pressure
Continuous Monitoring edema
Closely monitor vital signs, oxygen Septic Signs of Elevated or
saturation, and urine output. Be infection, often depressed
alert for signs of biphasic reactions warm white blood
occurring hours after initial extremities cell count
symptoms resolve.
Neuro- Initially History Bradycardia
Antihistamines genic of spinal cord with
Administer H1 antagonists (e.g., Injury, hypotension
diphenhydramine) and H2 warm/dry skin
antagonists (e.g., ranitidine) as Anaphy- Rapid onset, History of
ordered to help manage lactic urticaria, allergen
cutaneous symptoms. bronchospasm exposure
Corticosteroids
Give systemic corticosteroids to
help prevent biphasic or protracted Advanced Hemodynamic
reactions, although onset of action Monitoring in Shock
is delayed.
Central Venous Pressure (CVP)
Bronchodilators
Measures right atrial pressure,
Use inhaled beta-2 agonists for providing an estimate of preload.
persistent bronchospasm, in Normal range is 2-6 mmHg
addition
Pulmonary Artery Catheter
Provides data on pulmonary artery Antimicrobials
pressures, cardiac output, and
Broad-spectrum antibiotics are
mixed venous oxygen saturation.
crucial in managing septic shock
Useful in differentiating shock
and should be administered early
types.
based on likely pathogens and
Arterial Line local resistance patterns.
Allows continuous blood pressure Complications and Prognosis in
monitoring and facilitates frequent Shock
blood sampling for arterial blood
 Acute Kidney Injury
gases and lactate levels.
Decreased renal perfusion can
Echocardiography
lead to acute tubular necrosis and
Non-invasive assessment of potentially require renal
cardiac function, volume status, replacement therapy.
and potential causes of shock
 Acute Respiratory Distress
(e.g., pericardial tamponade)
Syndrome (ARDS)
Pharmacological Management
Inflammatory mediators and fluid
in Shock States
shifts can cause diffuse alveolar
Vasopressors damage, leading to severe
hypoxemia.
Medications like norepinephrine,
epinephrine, and vasopressin are  Disseminated Intravascular
used to increase blood pressure Coagulation (DIC)
and improve tissue perfusion in
Widespread activation of
shock states.
coagulation cascades can lead to
Inotropes both thrombosis and bleeding
complications.
Drugs such as dobutamine and
milrinone Improve cardiac  Multiple Organ Dysfunction
contractility and are particularly Syndrome (MODS)
useful in cardiogenic shock.
Prolonged shock can lead to
Corticosteroids progressive failure of multiple
organ systems, significantly
May be used in septic shock
increasing mortality risk
refractory to fluid resuscitation and
vasopressors, or in cases of
suspected adrenal Insufficiency.